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INTRODUCTION

Obesity remains a medical enigma (1).

Defying clear defin¬

ition as a clinical entity, a myriad of therapeutic approaches
to obesity have been attempted over the years with a remarkably
consistent low degree of success (2, 3)»

The approaches have

been diverse - medical, surgical, psychiatric, social - and
reflect the complexity of the problem of the obese state.

Re¬

cently an apparent increase in interest has arisen in the treat¬
ment of obesity, as reflected in the medical literature.

This

has likely been catalyzed by the relatively recent growing en¬
thusiasm and concomitant growing fear and skepticism over newer
methods of treatment: intestinal bypass surgery and behavior
modification.

A careful re-evaluation of the treatments of

choice for the obese patient is needed at this time.

In addi¬

tion to an examination and comparison of results of various
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treatment methods, it is important to reconsider the basic under¬
standing of obesity in order to rationally approach the prob¬
lem therapeutically.

Epidemiologic and etiologic considera¬

tions should not be forgotten, lest our means may obscure our
goals.

The potpourri of treatment approaches may be indicative of
the confusion and misunderstanding rampant among physicians
concerning obesity.

However, an eclectic approach could be

the result of good clinical judgement in individualizing treat¬
ment for a very complex problem.

More disturbing than the

variety of therapeutic approaches is the relative lack of any
approach.

Obesity is often not defined as a clinical problem

and, for a variety of reasons is too often ignored by the
physician in the clinical setting.

Perhaps the greatest de¬

terrent is the fact that obesity is so difficult to treat suc¬
cessfully.

This is undoubtedly discouraging, but clearly not

the only factor, as physicians treat many disorders despite
very limited success.

Underlying the problem of the treat¬

ment of obesity is the realization that obesity, unlike most
other clinical disorders, is to a great extent a moral issue
(4).

Obesity is often simplified into issues of will power

and gluttony - morally-charged items - and the burden and
responsibility of care is frequently thrust back upon the
shoulders of the obese patient.

Although some advantage may

be achieved through bolstering the patient's motivation and
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also limit-setting his dependency needs, the moralistic ap¬
proach has serious drawbacks.

It often reflects a physician's

ignorance about the obese state, and in its insensitivity to
the patient may be a disservice.

Again, a more rational ap¬

proach to the obese patient can be found after understanding
the basics of the clinical disorder and reviewing the results
of different therapeutic approaches.
One difficulty in the study of obesity results from the
incremental nature of this disorder rather than it being an ailor-none pathologic entity.

Clinically, however, obese patients

may present with seemingly different medical problems.

Commonly

seen is the mild or moderately obese patient whose obesity is
incidental or at most questionably associated with other health
problems for which he seeks relief.

Here, obesity is usually

looked upon as a symptom (5) and may or may not be viewed as an
important problem requiring treatment.

The massively obese pa¬

tient, on the other hand, perhaps presenting with a Pickwickian
syndrome, severe hypertension or other serious problems felt to
be directly related to a more obvious life threatening obesity,
is usually approached more aggressively for the treatment of his
major disorder of obesity.

The medical literature rarely makes

a distinction between these two groups of obese patients.

Such

a distinction is increasingly needed in obesity research now
that the more risky surgical approach is gaining acceptance.
This study will review literature about obesity in general.
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realizing that dividing obesity into quantified categories is of¬
ten unnecessary and impractical.

However, some attention will

be focussed upon the problem of massive obesity and its
treatment.
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THE OBESE PATIENT

Definition

A dictionary defines obesity as "excessive fatness,
corpulence, or overweight."

(6).Jean Mayer stresses that

obesity is a pathologic condition, characterized by an accu¬
mulation of fat much in excess of that necessary for optimal
body function.

(8).Salans similarly defines obesity as "a

disorder in which there is an abnormal enlargement of the adipose
tissue mass."

(9).Mayer makes a distinction between obesity

and overweight, the former meaning too much fat, the latter
less specifically meaning too much weight.

The heavily muscled

and boned individual is likely to be found overweight, but may
not be obese.

Swings in water balance may also affect weight

by up to several pounds.

A theoretical distinction between

obesity and overweight exists.

Accepting the concept of
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Mtoo much fat," one must consider the limitations of normal
body fat content.

In men, normal body fat content increases

with age from about 18-20% at age 20 to about 35% at age 60.
For v/omen the respective numbers are 20-25% and 25-30%.
(10).Equating obesity with adiposity is limited by the va¬
lidity of these ranges of normal values.

Is an elderly thin

man too fat because 30% of his weight is adipose tissue?

It

must also be kept in mind that normal ranges are usually de¬
fined by assuming a normal distribution and then choosing a
somewhat arbitrary boundary such as that defined by the stan¬
dard deviation from the mean, establishing the upper 16% of
the sample as above normal.

(8).The concept of normalcy is

further obscured when considering obesity in terms of hypo¬
thalamic regulation.

If an individual's hypothalamic regu¬

latory system is set to maintain fat stores at a high level (11),
then that person's obesity is a normal or ideal set point for
his body composition (12).
Although George Bray defines obesity as an enlargement
and/or hyperplasia of adipose cells, he stresses his conviction
that obesity is a symptom rather than a disease.

(21)"It rep¬

resents one visible consequence of ingesting more calories than
are being utilized"

(5).

He derives this notion from the appar¬

ent heterogeneity of the obese state.

Hilda Bruch states thats

"Obesity...must be looked upon as the outward manifestation of
a variety of underlying disturbances in weight and appetite
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regulation"

(14).

Even Mayer, who is convinced that a somatic

regulator underlies the process, sees obesity as multicausal,
a common symptom of numerous conditions, and therefore offering
multiple cures.(4)

Measurement

Accepting that obesity is a symptom of diverse causes
characterized by an overaccumulation of body fat, its clinical
measurement and assessment is a problem.

Indirect rigorous

laboratory measurements offer the most scientifically sound
method of estimating degree of adiposity.

Densimetric, hydro¬

metric (dilution), and body potassium determination methods have
been developed (4), but are not practical for clinical use.

Of

anthropometric measures, that of skinfold thickness remains the
best accepted.

The validity of this measure is based upon the

belief that subcutaneous fat, evenly distributed, is directly
proportional to total body fat in an individual for a given age
and sex.

It requires the use of a special caliper and some min¬

imal skill at least in measuring the thickness of a pinched skin¬
fold, usually over the triceps.
with standardized tables.

This measurement is compared

Although Mayer sees this method as

simple, practical, and precise (15)# its use in clinical settings
has not been popular and it remains a diagnostic tool of the
researcher and specialist.
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Measurement of height and weight remains the most used
method for determining obesity.

Standard tables take into

account height, body build, sex and age in setting limits for
normal weight.

The inadequacy of using weight to measure obes¬

ity has been mentioned, and can be both falsely high or low, as
Keys found twenty per cent of underweight men in the upper one
third of fatness distribution (16). The tables are derived from
insurance company data (17) which has been criticized as of
limited usefulness because of population skewing (18),

To re¬

duce inaccuracy introduced into normal range values by variations
in non-adipose tissue contributing to weight, the height-weight
tables show different normal weight ranges for small, medium and
large frame.
somatotypes

This variable relates to Sheldon's earlier work on
(19). Sheldon defined three basic genetic body types:

endomorphic, mesomorphic, and ectomorphic, based upon seventeen
anthropometric measurements.

Not only do these variations in

body build or type make obesity interpretation difficult, but
the somatotype itself may be closely associated with a predis¬
position to obesity.

Seltzer and Mayer found obesity to corre¬

late with endomorphy in adolescent girls (20).

In spite of the

limitations of the standardized height-weight tables, Bray found
a good correlation (r=+0.9) between table assessment of obesity
and adiposity measured densimetrically (21). To reduce the overinfluence of height in the use of the tables and increase accu¬
racy, the ratio

of weight/height squared, called body mass

index, was found to best correlate with adiposity (16).
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Subjective assessment of fatness can in most instances be
crudely accurate and may be helpful in detecting obese patients
who are not overweight.
often unreliable:

The mirror test is practical, although

if you look fat, you are.

TABLE 1
STATISTICAL BULLETIN METROPOLITAN LIFE INSURANCE COMPANY NO. 40
NOVEMBER-DECEMBER, 1959 DESIRABLE WEIGHTS IN INDOOR CLOTHING
Weight (lb.)
Height
Small frame

MEN
Aged
25
and
over

5'2"
3"
4"
5"
6"
7"
8”
9”
10"
11"
6'0"
1"
2"
3"
4"

112-120
115-123
118-126
121-129
124-133
128-137
132-141
136-145
140-150
144-154
148-158
152-162
156-167
160-171
164-175

Medium frame
118-129
121-133
124-136
127-139
130-143
134-147
138-152
142-156
146-160
150-165
154-170

156-175

162-180
167-185
173-190

Large frame
126-141
129-144
132-148
135-152
138-156
142-161
147-166
151-169

155-174
159-179
164-184
168-189
173-194
178-199
182-204

Weight
Height
4'10"
11"
5' 0"
WOMEN
1"
2"
Aged
3"
25
4"
and
5”
over
6"
7"
8"
9"
10"
11"
6" 0"

Small frame

Medium frame

92-98
94-101
96-104
99-107
102-110
105-113
108-116
111-119
114-123
118-127
122-131
126-135
130-140
134-144
139-1^-8

96-107
98-110
103-113
104-116
107-119
110-122
113-126
116-130
120-135
124-139
128-143
132-147
136-151
140-155
144-159

Large frame
104-119

106-122
109-125
112-128
115-131
118-134
121-138
125-142
129-146
133-150

137-154
141-158
145-163
149-168
153-173
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Prevalence

Not altogether independent from the determination of
normal values for weight, skinfold, or indirectly measured
adiposity, is the prevalence of obesity.

On the height-weight

tables (17) the upper limit of desirable weight is about five
per cent above the mean of a given range for a height and frame.
Desirability, in this case, has been based upon mortality data.
The U.S. Society of Actuaries in i960 found the following per
cent deviation from desirable weight (17,22)
% Of Population Weighing X% From Ideal Weight
Age (Years), Sex

50-59

a
a

50-59

9

20-29

-10%

+ 10%

10-19%

+20%

13

31

19

12

4

63

29

34

4

67

21

46

Although this very large study was limited to insured indivi
duals, smaller studies in the U.S. and Great Britain have
found between 18-34% of the adult population to be at least
10% overweight (23-■25).

In the New York City public school

stem, 10% of the children are overweight (26).

75% of obese

children are believed to go on to become obese adults, while
25%> of obese adults were obese children (27).

A more recent

Public Health Service report estimates that 25-45% of Ameri¬
can adults are greater than 20% overweight (28).

Generally,

clinical obesity is considered significant when excess weight
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is at 10-15%, and 20-30% overweight is excessive obesity (29).

Risks and Consequences

Although the prevalence of obesity is impressively large,
the clinical significance of obesity lies in the associated
risks, hazards, and liabilities that are caused by or related
to the obese state.
of obesity.

Two basic schools exist on the hazards

Mann has called obesity the "nutritional spook,"

(30) emphasizing that the evidence is weak correlating obe¬
sity with the disease states it is usually said to be associated
with.

Furthermore, Mann is impressed that "obesity is a re¬

latively incurable disorder,"

(27) which would imply that

the treatment may often be more drastic than the disease.
The more traditional point of view stresses that obesity is a
menace (31,4).
The hazards of obesity could be categorized as follows:
1- increased disease risk; 2- effect on established disease
or normal function; 3- social and psychological effects; 4costs and hazards of treatment.

Mortality statistics for

life insurance holders in the 1930's document, if only crude¬
ly, the considerably increased mortality risk for overweight
persons (see table 2)

(4).

Overall, the mortality for the

overweight population is 150% that of the normal.

Furthermore,

the mortality increases as the percentage of overweight in¬
creases.
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TABLE 2
PRINCIPAL CAUSES OF DEATH AMONG MEN AND WOMEN RATED FOR OVERWEIGHT
ATTAINED AGES 25-74 YEARS
Ratio of Actual to Expected Deaths According to Estimates
of Contemporaneous Mortality Experience on Standard Risks
Metropolitan Life Insurance Company, Ordinary Department
Issues of 1925 to 1934, Traced to Policy Anniversary,1950
MEN

Cause of Death
Principal cardiovasc.renal diseases
Organic heart dis.,
coronary artery dis
Cerebral hemorrhage
Chronic nephritis
Cancer, all forms
Stomach
Liver and gall bladder
Pancreas
Breast
Uterus
Diabetes
Tuberculosis (all)
Pneumonia
Cirrhosis
Appendicitis
Hernia and intestinal
obstruction
Gall bladder dis. (all)
Biliary calculi
Stomach and duoden. ulcer
Pueroeral conditions
Suicide
Accidents, total
Auto
Falls

WOMEN

% Actual
% Actual
of expected
of expected
Deaths
Deaths
Deaths
Deaths
1867

149

1103

177

1377
247
243
385
62
33
19

142
159
191
T7
85
168
93

175
162
212

—

--

697
226
180
4 76
34
46
21
81
103
235
20
78
32
41
31

—

--

205
24
98
96
76
39

383
21
102
249
223
15ft*

32
19
30

152*

—

63
177
76
32

Too
86
211
149
69
121
372
35
129
147
195
ra>

30
50

188*

67

---

--

—

43

78
111
131
131

23
74
27

162
73
135
120

206

2B4

** ***

*Based on mortality rates on Standard risks for 1935-1939
NOTE:

Percentages which have been underlined indicate statisti¬
cally significant deviations from experience on Standard
risks.
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Serious lifeshortening diseases said to be associated
with obesity include hypertension,
death,

diabetes mellitus, sudden

hyperlipidemia, respiratory insufficiency,

of pregnancy,
failure

thromboembolic disease, and congestive heart

(31-33).

Diseases of moderate to severe morbidity

said to afflict the obese include gallstones,
varices, hernias, menstrual disturbances,
and anesthetic risk (31f
dermatitis,

toxemia

flat feet,

34,

28).

osteoarthritis,

depression, anxiety

Minor disorders such as

impaired agility, and heat intolerance

can impair life style and, as has been reported in obese chil¬
dren,

can lead to serious accidents such as burns

(35).

Num¬

erous other problems less often associated with obesity have
been reported.
The Framingham Study found hypertension ten times as pre¬
valent in those 20% or more overweight as compared to normal
weight

(36).

Although other studies also show a significant

association between overweight and high blood pressure

(37»

38),

the degree of obesity has not been well correlated with hyper¬
tension (39).

In fact, the correlation between blood pressure

and adiposity has been found to be of low order in several
studies, between .05 and 0.3

(40,36).

McDonough et.

al.

found

a positive correlation in black women, but not black men in
their study in Georgia (41).

Body weight has been found to

better correlate with hypertension than has body fat

(36,42).

The use of weight as a measure for obesity rather than indirect
measures of adiposity allows for the influence of body build
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per se to remain uncontrolled for in most studies.

Mayer and

Seltzer have found a positive correlation between mortality
and body build

(20, 4).

Obese individuals are most often

endomorphic in somatotype, and least often ectomorphic

(4).

The contribution of bone and muscle mass as compared to adipose
tissue mass to increased mortality and morbidity in overweight
individuals is not yet clear.
The increased mortality for overweight people from heart
disease and especially coronary artery disease
implies a strong association.

(see table 2)

The Framingham Study found a

correlation for angina and for sudden death for those 20?S
or greater overweight

(43).

Keys also found a correlation,

but this disappeared when he considered only normotensive
overweight individuals

(44).

To add to the uncertainty,

other studies have failed to show a significant correlation
between overweight and coronary artery disease

(45,46).

As

obesity appears to be associated with hypertension and hyper¬
lipidemia (47, 48), and these conditions predipose to coronary
artery disease

(49),

it is reasonable to infer that obesity

is a potential culprit at least by association and possibly
by cause in a subpopulation of obese patients that have abnormalties in their blood pressure and serum lipids.
thermore,

Fur¬

it appears that obese individuals who suffer myo¬

cardial infraction with or without their obesity playing an
etiologic role are compromised in their ability to recover (43).
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Whether this increased rate of sudden death in the obese is
due to an increased hydraulic load upon the heart

(39)

or

poor collateral circulation due to the relative inactivity
associated with obesity (50),

or a combination of these

factors is not known.
The distinction between cause and association must be
kept in mind in these considerations of the hazards of obesity.
Associations between obesity and disease are often found,
particularly with the use of retrospective studies.

Disease

caused by obesity is better assessed through prospective studies
and requires difficult and sometimes unfeasible control of
multiple variables.

For example,

if a prospective study

shows a significant association between obesity and the on¬
set of coronary artery disease, we do not know whether a cause
and effect relationship exists or that some other factor such
as decreased exercise

(50-52)

is primary to both conditions in

these individuals.
The relationship between obesity and abnormal glucose
tolerance and diabetes mellitus is less controversial.
table 2).

Here,

(See

the disease state is more clearly related to

the physiological alterations which obesity causes in car¬
bohydrate metabolism.

The obese have been found to have in¬

creased fasting insulin levels, theorized as an adaptation
from active obesity (state of accumulation of fat)

for in¬

creased efficiency and rapidity in the removal of glucose
from the blood

(53).

It appears that the obese often have a
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decreased carbohydrate handling capacity,

that they require

more insulin to act upon adipose and muscle cells

(exacer¬

bated by an increased cortisol secretion), and that this is
clinically reflected in an abnormal glucose tolerance test and
sometimes leading to overt diabetes mellitus
study on human hyperphagia,

(5^#17).

In Sims'

normal male volunteers were overfed

to study the changes caused by exogenous obesity.
group which successfully reached 20% overweight,
glucose tolerance, increased insulin levels,
peripheral insulin resistance were found

In the
a diminished

and increased

(55t57).

A major mechanism of disadvantage in obesity is that of
mechanical burden;

obese people overwork their systems.

Al¬

though this is still somewhat controversial in the cardio¬
vascular system,
system.

it is more obvious in the muscular-skeletal

Arthritis,

fractures, and other muscular-skeletal

problems are often troubled by excess weight.

Respiratory

difficulty, manifested in extreme in the Pickwickian syn¬
drome,

is believed to be another mechanical consequence of

obesity (49).

When obesity is a mechanical burden to health,

the degree of obesity would seem to correlate with the degree
of disability.
Other mechanisms of disadvantage have been suggested.
Hypothetically, the increased food intake of the obese intro¬
duces the increase of ingestion of noxious substances
Indeed,

(27).

laboratory animals have been found to live longer

on a diet restricted to three-quarters of their usual intake

\

17-

-

as compared to a group on an ad libitum diet (58).

Decreased

physical activity might also play a role in disease predisposi¬
tion in the obese.

While a number of studies have shown an

association between inactivity and obesity (50-51* 59-61), and
some have implicated inactivity in an etiologic role (52), Sims'
work on experimental human obesity suggests that inactivity can
be secondary to the gain of excess weight (56).

The potential social and psychological consequences of
obesity are mostly obvious and can be devastating.

A long

social history of prejudice against fat people exists.

The

obese are somehow viewed as physically and morally absurd.
Anthropological precedents of obesity as an indicator of
success still have some meaning in our culture, but the pre¬
stige accrued upon the "fat cat" or the "buddha" in certain
settings is more than offset by the negative aspects of being
considered physically and often morally grotesque.

Mayer is

struck by the social attitudinal aspect of obesity (4), and it
may indeed be this quality of obesity, rather than a more
"medical" one, that makes it such a difficult disorder to
deal with successfully in a medical model.
Social ostracism and prejudice naturally relate to the
psychological trauma of obesity.

Although it is difficult

to separate psychological problems that are causal from those
consequential to obesity, disturbances in self-esteem, sexu¬
ality, and body image, as well as neurotic depression may be
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manifested.

Hilda Bruch emphasizes that obesity is associated

with many psychological disorders, rather than just one.

In

obese children, their development centers around their fat¬
ness.

While eating freely, they tend to avoid activities and

contacts, not unlike the situation described for the symbiotic
preschizophrenic family (14).

A number of investigators have

found evidence of greater psychopathology in obese versus
nonobese

patients on the basis of psychological testing or

clinical evaluation (62, 63).

These studies, however, do not

determine whether the psychological disturbance is primary or
secondary to the obesity.

The psychological aspects etiological-

ly related to obesity will be discussed in another section.

Not to be forgotten amongst the hazards of obesity are
those resulting from weight reduction therapy.

In addition to

the side effects of drugs, fasting, intestinal bypass surgery
(to be discussed when considering these treatments), abused
methods, and folk remedies, even moderate dieting can produce
untoward reactions.

Stunkard has reviewed the literature link¬

ing diet with depression and concludes that untoward emotional
reactions to diet are a real phenomenon especially in patients
with juvenile onset obesity undergoing severe caloric restric¬
tion as outpatients (64).

Bruch warns that:

...for many people overeating and being fat
is a balancing factor in their adjustment
to life.
Ineffective as it is, it represents
the best form of adaptation that such people
have been able to make. (65)
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Thus is the concept viewing obesity as a depressive equiva¬
lent for some individuals (66).
Other hazards have been reported.

Mortality data indicate

significantly raised death rates in overweight people for a
number of surgical disorders such as appendicitis, hernia,
gall bladder disease, and intestinal obstruction (17).

Other

relatively obvious risks exist, although seldom documented.
For example, physical examination of the abdomen is often
difficult in the obese patient and important physical findings
are frequently not detected.

Less obvious risks have also

been reported, such as the association between nephrotic
syndrome and massive obesity (67).
The purported benefits of obesity should be mentioned.
Mortality data imply a significant decreased risk for breast
cancer, tuberculosis, peptic ulcer, and suicide.

It is un¬

known whether these benefits are truly obtained through adi¬
posity or by some other variables common to the group of
overweight patients.

The theorized anti-depressant effect of

obesity has been mentioned, and Simon found overweight Air
Force men less depressed than their normal peers (66).

In sum, the hazards of obesity are numerous and diverse,
including physical and psychological problems, from trivial
to life threatening, and through a variety of pathogenetic
mechanisms.

Controversy arises concerning the degree that
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obesity predisposes to hypertension and its related serious
diseases of the cardiovascular-renal systems.

Diseases more

clearly related to physiological disturbances brought on by
the obese state, such as diabetes mellitus, are more closely
associated with obesity.
The benefit of weight reduction in terms of relieving the
hazards of obesity is a major consideration for initiation of
therapy.

Marks found a return to normal mortality rates for a

group that had successfully lost weight (37).

This data,

however, is crude and imperfect and a good study testing whether
weight loss in obese subjects lowers their risk for certain dis¬
eases is relatively unfeasible.

Mann asserts that weight reduc¬

tion for hypertension is not reasonably worthwhile considering
the infrequency of successful treatment (27).
An individualized risk-benefit analysis seems prudent in
the decision to treat patients for obesity.

The following salient

points should be kept in minds
1)

Obesity carries with it numerous and various potential

consequences to an individual’s physical and emotional health.
2)

Weight reduction will relieve or prevent these conse¬

quences to a varying and uncertain degree, depending largely
upon the physiological relationship of adiposity or over¬
weight to the consequence, and the reversibility of the con¬
sequence.
3)

Weight reduction therapy is generally lengthy and costly,
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accompanied by a variety of potential side effects, depending
on the method, and, for the most part, is unsuccessful in the
long run.
Therefore, no hard and fast rule can be applied to the ques¬
tion to treat or not to treat.

Patient mctivation is, of

course, another important variable, and will be discussed when
considering treatment efficacy.

Classification

The classification of obesity has undergone several revi¬
sions in its basic scheme this century.

Van Noorden intro¬

duced the endogenous-exogenous classification at the turn of
the century (5)» and it is still often used today.

Exo¬

genous implies that the obesity is caused by overeating,
while endogenous obesity implies some explainable physiologic
or genetic mechanism.

While of some practical use, such as

differentiating between endocrine causes and so-called dietary
causes, this classification falls short in its theoretical
accuracy.

There is formidable evidence, to be discussed

shortly, that would lead us to believe that so-called exogenous
obesity is no more exogenous or unphysiologic than the endo¬
genous obesity seen in Cushing's syndrome.

Clinical use of

this categorization is further hampered by connotations that
these labels have taken on over the years: exogenous obesity
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as the result of an incorrigible and immoral gluttony versus
the respectable and treatable disease-caused endogenous obesity.
A more recent development has been the so-called anatomic
classification: hypertrophic versus hyperplastic obesity.

A

potentially important categorization arose on finding hyper¬
plasia of adipocytes in juvenile onset obesity, and only
hypertrophy without increased cellularity in the adipocytes
of patients who first became obese in adulthood (72-75).

The

potential therapeutic relevance of these findings are felt in
light of the understanding that weight reduction will decrease
adipocyte size but not cell number (74, 76).

Interest has been

sparked in early life and the factors that increase cellu¬
larity.

Knittle and Hirsch found they could modify cell number

in young rats nutritionally, implicating the importance of
ovemutrition in early life in juvenile onset obesity (77).
A number of classification schemes based upon etiology or
clinical types have been devised (4,5)(78,79).

(See table 3).

While Mayer limits his classification to genetic, hypothalamic,
and endocrine categories (4), Bray adds to this group the cate¬
gories of inactivity, drugs, and essential obesity (5).
Within this classification, simple obesity, considered as a
genetic obesity, is by far the most common, and the type that
interests us the most.
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table 3
CLASSIFICATION OF OBESITY IN MAN:
Modified from Bray (5)

ETIOLOGIC

Hypothalamic
Tumors
Solid (Frohlich syndrome)
Leukemia
Inflammatory
Traumatic
Increased intracranial pressure
Empty sella
Pseudotumor cerebri
Endocrine
Cushing's syndrome
Insulinoma
Castration
Stein-Levinthal syndrome
Pregnancy
Hypothyroidism
?Inactivity
Genetic
Simple;
Juvenile onset
Laurence-Moon-Biedl syndrome
Hyperostosis frontalis interna
Alstom's syndrome
Prader-Willi syndrome
Drugs
Phenothiazines
Estrogens
Cyproheptadine
Etiology

The understanding of the etiology of a disease is often
the key to the development of an effective treatment.

Obesity t

hardly well conceptualized as a disease state, suffers the
dilemma of etiological uncertainty, which has likely contri¬
buted to its relative refractoriness to a variety of imperfect
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therapies.

However, obesity is the result of any of a multi¬

plicity of causes, and likely can be approached, theoretically
at least, through a number of potential cures (4).
Mayer has stressed the importance of animal studies in
understanding human obesity:

"Is man indeed unique as far as

normal - and pathological - fat accumulation is concerned?"(4)
Animal husbandry is an example of genetics operating in obesity
outside of the laboratory setting.

A number of rodent models

exist of genetically determined obesity (4,68).

The yellow

mouse transmits obesity by autosomal dominance, while several
other mice strains show autosomal recessive transmission.
Obesity is also observed in a number of inbred strains such
as the New Zealand obese mouse and the Japanese K K mouse.
Although these genetically determined obese animals have a
number of characteristics in common, such as hyperphagia,
inactivity, hyperglycemia, and hyperinsulinemia, no clear
biochemical basis for explaining the obesity has been deter¬
mined (5).

Human studies indicate that genetics plays a role in obesity.
Newman found identical twins separated at birth to be signifi¬
cantly closer in weight than a group of fraternal twin controls
(69).

More recently Shields found separated monozygotic twins

closer in weight than dizygotic twins reared together, impli¬
cating genetics as more influential than environment in body

25-

-

weight (70).

Work earlier this century showed stoutness to be

transmitted as a Mendelian inherited dominant trait (71).
Gurney found the following in the population he studied (39).
Parents
stout; x stout
stout X nonstout
nonstout x nonstout

Stout Offspring
73%
40%
9%

Worth mention are a number of reported hereditary syndromes
that include obesity in their constellation:

Laurenee-Moon-

Biedl, hyperostosis frontalis interna, Alstrom's, and the
Prader-Willi syndrome (5).
Although the evidence is strong that hereditary factors
contribute to the emergence of the formerly labelled exo¬
genous obesity (less controversially called simple obesity by
Mayer (4)

), it is less clear to what extent this is true.

multiplicity of genes is likely involved (4).

A

Evidence suggest

that hyperplastic obesity, the juvenile onset type, may be
genetic.

Endocrine obesities, it should be stressed, are relatively
rare as compared to simple obesity.

Cushing's syndrome is

perhaps best known, the hyperadrenocorticism producing a
characteristic clinical and laboratory picture, including a trun¬
cal, posterior cervical, and superclavicular fat distribution.
Hyperinsulinism is another endocrine abnormality that can

produce obesity (81).

The pathophysiology of insulinomas is

relatively clear, but the hyperinsulinism and associated
weight gain frequently known to precede diabetes is less well
understood in its relationship to obesity.

Sims showed that

hyperinsulinism and abnormal glucose tolerance could occur
after a significant weight gain in overfed subjects (55)»
although evidence of these insulin changes preceding obesity
in the prediabetic has not been established.
Of some appeal is the concept that obesity is the result
of a hypometabolic state.

The endocrinological prototype of this

phenomenon is best seen in hypothyroidism.

These patients have

a decreased metabolic rate and tend to gain weight, although
it is unclear how much of this weight gain is due to fat and
how much is fluid.

Hypothyroidism, however, needs be verified

by thyroid function tests and not diagnosed solely on the
basis of a basal metabolic rate (BMR) measurement, as has
been done so often in the past.

Although it is quite possible

that the obese bum up less energy in their daily activities (82),
BMR studies have mostly shown no difference from normals (29).
Passmore found that obese patients gained more than thin pa¬
tients when overfed for fourteen days (83,84).

Such evidence

that the obese are not as capable of burning up extra fuel
may relate to Roily's observation in 1921 that the thermal
response to food is decreased in obesity (29).

It is theorized

by some that the thermal effect of eating - the specific dynamic
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action of food - allows normal individuals to maintain weight
with varying intakes.

In Miller's thermogenesis theory the

specific dynamic action decreases in obesity (85).

Galton

has postulated a possible enzyme deficiency based on his evi¬
dence that the obese have reduced ability to oxidize glyceral
phosphate, leaving more glycerol available for fat syntheses(86).
These metabolic findings and theories are of yet unclear
importance in the etiology of obesity.

More likely may be

their importance in the maintenance of the obese state.
Craddock summarizes that the metabolic differences between
the obese and normal are "...of degree only and are due to
adaptation to an abnormal intake of food at some time."

(29)

Other endocrinological diseases associated with obesity
are a number of varying gonadal disorders.
is often associated with a truncal obesity.

Male hypogonadism
Stein-Leventhal

syndrome, or polycystic ovary disease, consists of hypo- or
amenorrhea, often infertility, hirsutism, and sometimes
obesity in young women.

These women show increase adrenal and

ovarian function, and a hyperphagia and weight gain that
has suggested hypothalamic involvement in the process, al¬
though there is little data to support this (87).

Hypothala¬

mic lesions have also been suggested in Frohlich's syndrome,
inwhich truncal obesity is associated with sexual infantilism,
and often other abnormalities.

This syndrome may be associated

with tumors and other disorders of the hypothalamic pituitary
area and, like the rare hereditary Laurence-Moon-Biedl syndrome.
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obesity and genital atrophy are assumed but as yet unproven
to be the result of hypothalamic dysfunction.

Although of great importance theoretically, hypothalamic
obesities are rare.

Three pathologic groups exist:

inflammatory, and neoplastic.
the craniopharyngioma (5).

traumatic,

The most common cause has been

Animal experiments have uncovered

the physiology of the hypothalamic regulation of satiety and
hunger.

Destruction of the ventromedial area of the hypothalamus

caused a number of different animals to overeat until obese.
Destruction of lateral hypothalamic areas produced animals that
would not eat.

On the basis of these and other findings the

mechanism for the regulation of food intake has been postu¬
lated:

a satiety center in the ventromedial nucleus and a

feeding center in the lateral hypothalamus, with connnections
between the two centers (4, 49).
Subsequent theories have integrated the appetite centers
into a scheme of abnormal regulation.

"Glucostatic," "lipo-

static" and "aminostatic" theories of food intake have emerged
with the basic idea that some blood factor, falling below a
critical level, stimulates hypothalamic centers through speci¬
fic receptors, producing the drive to eat.

Mayer's glucostatic

theory has received widest interest (4, 29), postulating that
hypothalamic glucoreceptors register low levels of effective
blood glucose in some individuals causing them to eat more.
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V/hat has emerged has been the concept of obesity, in many
if not most cases, as a disorder of hunger and satiety regu¬
lation.

It seems likely that an individual, based upon his

genetic predisposition and early nutritional experience, has
his regulatory mechanism for food intake set at a certain
level.

For the obese, this level is set high.

Indeed, there

are many physiological and behavioral similarities between the
obese man and the normal hungry person (12).

Both obese and

hungry subjects have been found to eat faster (88), to more
readily eat in a new environment (1$, and to prefer good over
bad tasting food (33» 89) more so than normal controls. Schacter
has conducted a number of studies of eating behavior that impli¬
cate poor regulation of intake or an insensitivity to physio¬
logical cues in the obese (88, 90).

These behavioral eating

patterns of obese and hungry subjects are similar to those found
in animals with experimental ventromedial hypothalamic lesions.
A physiological index of hungry, free fatty acid in blood, is
found to be inflexibly elevated in obese subjects (91).
The clinical implications of this view of obesity are pro¬
found.

If the obese patient "overeats" to meet the needs of a

true physiologic hunger, how successful can he be in first losing
weight and then maintaining his weight against a chronic hunger?
Such a situation could help explain both the high failure rate
for long term weight reduction and the phenomenon of dieting
depression.
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Another seemingly important factor in the unsimple etio¬
logy of simple obesity is that of inactivity.

Basically,

obesity is the result of a positive caloric balance:
absorbed is greater than the energy expended.

the energy

This balance is

exquisitely regulated in normal individuals who can generally
eat as they please and maintain their weight, even though an
imbalance of only one hundred calories per day could lead to
an accumulation of ten pounds of fat over a year.

Rats were

found to maintain a stable weight on an ad libitum diet when
they were exercised between one and five hours per day.

Below

one hour, however, the regulatory mechanism seemed to fail,
and the rats gained weight (92).

Mayer*s study of Indian indus¬

trial workers showed a similar phenomenon.

(See figure 1).

Over a range of light work jobs through very heavy work jobs,
workers maintained normal weights by natural variations in
their caloric intake.

However, workers in sedentary jobs

weighed more than their active fellow workers and showed a cal¬
oric intake greater than others expending more energy (52).
Other studies have linked obesity with inactivity, if not as a
cause, then at least as a factor contributing to its mainte¬
nance.

Chirico used pedometers (50) and Bullen used time

lapse motion pictures (51) to show that obese subjects were
less active than controls.

Sims, who overfed normal volunteers,

found his subjects more inactive when they became obese (55)*
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FIGURE 1
BODY WEIGHT AMD CALORIC INTAKE AS
A FUNCTION OF PHYSICAL ACTIVITY IN MAN
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A behavior as complex as eating must include consideration
of psychological factors in its etiology.

In the 19^0's

many considered obesity as the expression of a neurosis (29).
This simplistic view has fallen out of vogue in light of a
more sophisticated neuro-humoral understanding of obesity.
However, evidence still implicates the importance of psycho¬
logical factors.

A number of studies have found obese sub¬

jects to score more abnormally than controls on a variety of
psychological tests (62,63,93)*

Bruch and Yudkin have articu¬

lated the concept of compensatory eating (65*9*0:

a basic need

to have a large body to compensate for inferiority feelings.
Stressful or anxiety-provoking situations cause some obese
individuals to eat more (95)•

Stunkard postulates that some

obese have serious disturbances of body image (96).

In this

maze of theory we must respect Bruch's reminder that obesity is
probably associated with a number of psychological disorders,
not one, and her caveat that identifying psychological problems
as a cause of obesity versus an effect of weight reduction is
very difficult (14).

Craddock's statement seems functional

even if of unproven accuracy:

"The majority of obese people

probably have no obvious psychologic factors affecting their
tendency to obesity"

(29).

Nevertheless, Bloom and Clarke's

invention of the descriptive term "Obese Carboholic"

(97)

reflects the view that many clinicians take towards their
obese patients:

victims of a psychological addiction and

physiologic craving for food.
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Interacting with the psychological factors relevant to
becoming obese are a number of social factors. The Mid-Manhattan Study found only 5% of upper class women overweight
contrasted to 30% for the lower class (98).

Social eating

and exercise habits, education, ethnic and societal differ¬
ences, and cultural sexual role differences can all affect
one's tendency to become obese.
The inadequacy of classifying simple obesity as a genetic
obesity is obvious after considering the complex metabolic,
psychological, and social factors relevant.

However, such a

classification can be helpful in defining other obesities in
which the etiology is better understood.

Craddock's concept

of the etiology of simple obesity well depicts the interplay of
a variety of factors that may lead to obesity (29)•
(See Figure 2).___
°
~ Figure 2
THE ETIOLOGY OF SIMPLE OBESITY
( Modified from Craddock (29) )
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Summary and Conclusions

The definition, measurement, prevalence, hazards, classifi¬
cation, and etiology of obesity have been reviewed and con¬
sidered.

Accepting the definition of excess adiposity, clini¬

cal measurement is practically limited to indirect measurement,
height and weight tables being accurate for most cases, and
skinfold thickness measured by caliper offering greater accuracy.
Prevalence data indicate that obesity is very common, although
reports vary.

The hazards of obesity are numerous and varied,

some obvious and others controversial, some trivial and others
life-threatening.

V/eight reduction will clearly alleviate and

prevent certain problems of the obese, but it is of uncertain
benefit for other problems.

Obesity has been classified and

reclassified, based upon newer etiological understandings.
Numerous disorders of both man and animal are associated with
obesity, but these are relatively rare as compared to simple
obesity.

Recently divided into juvenile and adult onset types

based upon anatomic differences of the adipose tissue, simple
obesity appears to be influenced by genetic, metabolic and be¬
havioral factors in its genesis and maintenance.

Although

several appealing theories exist, a clear etiologic understanding
of obesity awaits further progress, and weight reduction therapy
through establishing a negative caloric balance can be approached
via a number of routes by which obesity is influenced.
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treatment

Introduction

The decision as to whether or not to treat an obese pa¬
tient is a problem that has been discussed in the section
considering the hazards of obesity and benefits of weight re¬
duction.

Worth reitering is the point that this is a dynamic

decision for the physician and the patient in which many var¬
iables need be considered in a risk-benefit model.

Mayer's

contention that weight reduction is desirable for all obese
patients

(8) lacks realism, while Mann’s view dubbing obesity

as the "nutritional spook"
its approach.

(30) seems unduly conservative in

More appropriately, no hard and fast rules

need be made concerning indication and contraindiction as long
as the patient's total well-being is of utmost priority.
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A distinction ought to be made between patient education
and actual patient treatment for obesity.

The former includes

disclosure to the patient that he is clinically overweight,
that this condition is hazardous to his health, and that it is
advisable for him to reduce his weight towards normal.

This

is clearly a service to most patients and will undoubtedly
often result in some small degree of success, especially when
the physician-patient relationship is particularly strong.
However, a clear and well-thought out treatment plan is more
appropriate if the physician seriously seeks a successful out¬
come for the patient.

It has been shown that some fifty per

cent of obese patients seen are not treated, even when greatly
overweight (100).
The wide variety of treatments for obesity reflect both
the multiplicity of etiologic avenues that have been theorized
and the failure of any single method to be satisfactorily effec
tive for most patients.

However, a common denominator exists

in all reasonable methods:

a negative caloric balance must

be achieved to lose weight, and over the long run, caloric
balance must be equilibrated to avoid regaining the weight.
Feinstein has pointed out that although a plethora of
methods exist, there is little scientific data to help the phy¬
sician decide which is best.
several caveats:

In evaluating methods, he offers

success should be based upon relative achieve

ment of target weights; dropout need be considered; follow-up
need be considered; guard against bias (101).
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Several criteria have been devised to measure the success
of weight reduction methods, such as rate of weight loss,
amount of weight lost, or per cent of excess weight lost. These
criteria, Feinstein has noted, are not valid in that they are
too greatly affected by initial weight or early program dropouts.
His reduction index relates loss to both initial weight and
surplus weight, but without being influenced by duration (102).
Reduction Index= % of weight loss x relative initial
obesity = weight loss/weight surplus x initial weight/
target weight x 100
Feinstein considered an index of sixty as successful.

Target

weights can be determined from height/weight tables or based
upon clinical judgment.

Since its introduction some fifteen

years ago the reduction index has seldom appeared in the litera¬
ture and the degree of its use is unknown.

Diet

The diet has long been the mainstay of obesity therapy.
Its appeal lies in that it is "natural”, introduces a minimum
of iatrogenic manipulation, is inexpensive, and is syntonic
with the concept that obesity is an eating disorder.

And,

indeed, calories do count - a concept that appeals to the lay
scientific mind of contemporary man.

The basal metabolic rate

for man calculates to about 1000 calories/square meter/day;
the 5'10" 150 pound man having a surface of about 1.7 m^.
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Daily activity burns calories in excess to the BMR an average
of sixty per cent for adolescents and some forty per cent for
those over the age of sixty (103).
ture can vary markedly,
day for a male
3500 calories

(4).

However, energy expendi¬

ranging between 2400 and

6000 calories/

A pound of fatty tissue contains about

(104).

Despite these metabolic realities,

dieting has been largely

unsuccessful in the long term treatment of obesity.

Stunkard

reviewed literature reported over a ten year period,

finding

under twenty-five per cent of all patients undergoing treat¬
ment having lost up to twenty pounds, and about five
having lost as much as forty pounds

(2).

per cent

Finding only eight

follow-up reports, he located only two out of one hundred
patients who lost tv/enty or more pounds and who maintained
their loss after two years.

A number of other reports and esti¬

mates give these success rates for dieting regimens;
per cent of patients lose weight after one year;
per cent maintain some loss after five years

ten-forty

one to thirteen

(23f29»101,105-109).

A wide variety of diets have been used to achieve an overall
decrease in caloric intake.

Simplest of these is the prescribed

low caloric diet that is well-balanced - what might be called
a "common sense"
usually fails,

diet.

Obviously,

this common sense approach

or otherwise it would preclude the numerous

other diets that have appeared.

Significantly decreasing food

intake is clearly difficult for most obese persons,

explainable

by some of the psychological and physiological factors mentioned.
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Defaulting is a major impediment to success.
most notably methylcellulose,

Bulk agents,

have been tried in the hope

that satiety could be achieved through both psychologic and
physiologic mechanisms of eating and filling the stomach with
moderately large amounts of food.
benefit of use of bulk agents

(110)

A large study found no
and it is suggested that

naturally bulky foods - fruits and vegetables - can serve as
well

(4).

The use of artificial low carbohydrate foods and

sweeteners is another attempt to lessen the burden of a de¬
creased caloric intake.

Used widely in a program in which

calories are truly saved,

these "diet foods"

can be helpful,

but their impact has been minimized because of unpalatability,
expense,

the low appeal of synthetic chemicals in food,

and

their use without a well-planned reduction program.
Because of the difficulty of compliance with the low
caloric diet and its high failure rate, special diets have
been devised that are less harsh in terms of decreased food
but will purportedly reduce weight if adhered to because of
manipulation of foodstuffs in the diet.

The recommended

balanced diet ought to contain a minimum of lk% protein, a
maximum of 30% fat,
drate

(4).

and the remainder of calories as carbohy¬

Kekwick and Pawan postulated that a fat mobilizing

substance produced after fat ingestion led to an increased
weight loss in subjects on diets high in fat over subjects on
other isocaloric diets

(111-115).

Pennington began using the

"high fat" diet on his obese patients with some success about
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twenty-five years ago

(116), and the diet was subsequently

modified by Donaldson who added large water intakes to the
regimen (29).

Yudkin found that strict carbohydrate control

was all that was necessary for a successful diet, allowing his
patients a free fat and protein intake

(117).

Although others

have demonstrated the effectiveness of low carbohydrate/free
fat and protein regimens

(118,

97)»

Pilkington contends that

the diet seems to work because of the high fluid retention of
carbohydrates

(119), while Young claims that evidence implies

an increase in fat metabolism (120).

Another metabolic mechan¬

ism that might favor a diet high in protein is the high specific
dynamic action of this foodstuff which would theoretically dis¬
sipate some protein calories.
The major advantage of the free diet is clear:
enough for the dieter to allow success.

Craddock,

make it easy
an advocate

of the free diet, writes:
That the free diet is satisfactory for use in
general practice is shown by the fact that almost
every patient who takes his dieting seriously can
lose weight for a month or two even if he has not
the motivation to maintain dietary control for a
longer period (29).
Such claims have been challenged,

however, and a number of

studies have found no benefit of special diets with a variety
of foodstuff ratios over the balanced diet (121,122,129)
foods contain mixtures of fat,

Also,

protein and carbohydrates and

significantly altering the ratios of these foodstuffs from that
of a normal diet is difficult to achieve.

The benefit of the

free diet is further obscured by the criticism that it is unsafe
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nutritionally - particularly in promoting hyperlipidemia
through a high fat intake - fails to guide the obese patient
towards new healthier eating habits.
Another special diet devised to make compliance easier
has been the formula diet.

Here,

the patient is permitted one

or several prepared nutriment fluid meals per day and no
other caloric food.
safe,

It claimed the advantage of being simple,

and by offering the patient a rigid but simple regimen

to follow was conducive to high compliance and success.
early trials were promising (102),

Although

the formula diet faded

quickly as a popular method.
Recently, Sohar carried out a follow-up study of 27 patients
that had successfully dieted fourteen years previously.

More

than two-thirds of the group showed no substantial decrease from
their pre-diet weight;

only five had lost more than ten per cent

of their weight, while three had gone on to gain more than ten
per cent

(123).

Is dieting a worthwhile treatment?

George Bray

and George Mann, with long and scholarly interests in the field,
think not
mind:

1)

(27,124).

This view is derived with the following in

dieting is often arduous and emotionally and physic¬

ally upsetting;
inconvenience;

2)
3)

it is an expense

(professional care)

and

it often fails to reduce weight short term,

and usually fails long term;

4)

(Mann)

- weight reduction is

often unnecessary for the well-being of the patient.
Why do diets usually fail?

The concept that likens the

obese person to a normal hungry person (12)

(both neurohumorally
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and behaviorally), discussed previously, allows us to under¬
stand how difficult it must be to voluntarily abstain from
food in the face of a constant and powerful basic human drive:
hunger.

Psychological factors have also been mentioned, and the

obese patients who use eating in response to or in relief of
emotional stress (compensatory eating)
tremely difficult to diet.
described in two phases:

(24) may find it ex¬

Weight loss in the dieter can be
an initial fluid loss, often an

encouragaing start, then followed by a slower and more gradual
loss that represents the catabolism of fat (125).

This second

stage can be frustrating to both patient and physician.

As

discussed earlier, the obese are highly efficient in utiliz¬
ing calories, probably through metabolic adaptation (226, 83,84),
and this is compounded by a tendency to adapt to caloric restric¬
tion by decreased energy expenditure (12?).

The result is a

disappointing degree of weight loss that is less than the
predicted amount even though the patient has adhered to the diet.
Another vital factor relevant to the success or failure of
a diet is that of patient compliance.

Feinstein found re¬

stricted environment programs - inpatient programs that assured
the necessary discipline - superior to unrestricted environment
programs, and found the degree of successful weight loss to be
directly proportional to the amount of caloric restriction (102).
Based upon his analysis of methods, Feinstein defined three inter-
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I
actional factors that influence diet adherence;
1)

Patient: variety of psychic factors;

2)

Patient-physician relationship;

number of visits;

clinic availablility;

motivations

role of the doctor;

incentives by physician;

physician attitude
3)

Diet program:

factors which tend to keep patient

on program - enthusiastic beginnings and novelties.
He concludes that the particular diet is least important in
success,

that the physician - patient relationship is most

important,

and that "when a patient is ready to diet,

he can

lose weight with whatever method of caloric restriction is
given him."
The importance of motivation has also been noted by others.
Craddock found that his obese patients v/ith medical reasons
for losing weight did twice as well as his other obese pa¬
tients

(29).

Of note is that the best long term results of

dieting for a large program were reported for the Anti-Coronary
Club of New York - a group of highly motivated volunteers

(109).

The patient-physician relationship is of importance in any medi¬
cal regimen that calls for voluntary patient compliance.

Crad¬

dock emphasizes the need to individualize therapy as best suited
to each patient.

Besides taking a history and doing a physi¬

cal examination, he administers a psychological test - the
Shipman Anxiety/Depression Scale questionnaire(128)

- to help

determine neurotic tendencies that might alter treatment and
prognosis.

He stresses the importance of physician interest,

44-

-

especially in terms of advising and educating the patient
about a suitable program,
weeks at first,

and sees his patients every two

and then monthly (29).

As Hollenberg has stated

Successful management (of obesity) when it dees
occur, is the result of a knowledgeable and
sympathetic physician having the time and the
interest to meet repeatedly with a patient
who has at least a modicum of insight into
the condition and a considerable motivation
to reverse it (29).

Exercise

The therapeutic partner to the diet is exercise.

This is

logical in light of our understanding that calories do count.
The role of inactivity in the etiology of obesity has been
discussed,

as has been mentioned the wide range of caloric ex¬

penditure found in people with different activity levels.
Exercise alone cannot be considered a reasonable weight reduc¬
tion program.

As Mayer has shown,

increased energy expenditure

is naturally offset by increased caloric intake in the nondiet¬
ing individual

(52).

Increasing energy expenditure without a

matching increase in intake can be an effective part of a
weight reduction program.

Energy expenditure is proportional

to body weight for a given exercise, making this a self-cor¬
recting factor in the active person (4).

A three mile walk in

one hour burns only about three hundred calories, but Keys
calculates that a 190 pound man v/alking an hour daily for three
months will lose an additional ten pounds

(129).

(See Table 4)
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TABLE 4
ADDITIONAL WEIGHT LOSS FROM EXERCISE
Modified from Keys and Craddock (29)
One hour's walking daily (or 3/^ hour's bicycling
or 1/4 hour's swimming or l/2 hour's tennis)

-p

CD

•
WrO
• H i— 1

One Month
lb.

130

2.2

145

2.5

l6o

2.8

175
190
225
25b

3.1
3.4
3.9
4.3

Craddock concludes:

Two Months
lb.

4.4
4.9
5.5
6. 0
6.5
7.7

8.6

Three months
lb.

6.5
7.3

8.1
8.9
9.6
11.3
12.7

"an increase in the amount of regular

exercise taken should be part of the weight reduction regime
for every patient with no medical contraindications:
However,

(29).

the benefit of exercise may not be so predictable.

Buskirke has shown that when obese patients increase their
energy expenditure and restrict their intake,

they compensate

by conserving energy for the remainder of their nonstrenuous
activities

(130).

Little has been written about which individual factors are
associated with a good or poor prognosis for successful treat¬
ment.

Not surprising is the observation that obese adults who

were obese as children are less likely to succeed in weight re¬
duction and maintenance

(109).

The recent anatomic distinction

between juvenile and adult onset obesity may help explain this,

46-

-

but psychosocial factors are also likely to be contributory.
Also well known is that massive obesity is a more difficult
problem than obesity of a more moderate degree.
factors could easily explain this.

Again,

several

Craddock, who admittedly

sees little massive obesity in his practice, has identified a
number of prognostic factors in his obese patient population (29).
He reports that his patients with high incomes did better.

This

is probably a cultural phenomenon, and class values and educa¬
tion may play a role as well as enhance physician-patient rap¬
port.

Craddock reports that patients with medical incentives

to lose weight did twice as well as the other patients.
importance of motivation has been discussed earlier,
no motivation is as strong as a medical one.
observation that exercisers did better.

109,

badly.

242).

and perhaps

Of note is his

Other favorable prog¬

nostic characteristics include male sex, married,
(29,

The

and parents

Patients with a strong compulsion to eat do

Craddock concludes:
The patient who has the best chance of dieting suc¬
cessfully. ..is a successful businessman or profes¬
sional man who has become moderately obese during
his
adult life, is married with children, emotionally
mature, and with no marked tendency to depression.
His success will be quicker if he can take extra
exercise and if he has a medical reason for losing
weight.
Unfortunately, less than 10% of the patients
with a weight problem who present themselves to a
physician come into this category.

Drugs
While diet and exercise have the appeal of simplicity,

their
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relative lack of success has led to a search for a medical
treatment for obesity.

Bray predicts that ultimately a success¬

ful treatment for moderate or severe obesity will be pharma¬
cologic

(131).

However, no drug thus far has shown outstanding effectiveness
and drug treatment is considered an adjunct to a dietary pro¬
gram and not a reasonable treatment without dieting.

A great deal of experience exists with the use of appetite
suppressing agents of the amphetamine type.
agents,

These numerous

all bearing chemical resemblance to the parent compound

D-amphetamine probably produce relative anorexia through stimu¬
lation of the ventromedial hypothalamic satiety center (4)
through another central nervous mechanism (132,

133)*

or

although

peripheral metabolic process have also been suggested as contri¬
buting to their effectiveness

(134).

The effectiveness

of these

agents on weight reduction over placebo has been documented in
numerous studies

(135-1^0)•

Using well-controlled and double1

blind methods

(138), the literature supports the effectiveness

of these agents even in the face of the difficulty of isolating
drug effect from variables related to the dieting regimen.
well documented is the limited duration of these drugs'
(141).

Also

effects

Most of the above studies documented positive results

for twelve weeks or less, and four to six weeks may be the
optimal period for most patients
an anorexiant

(diethylproprion)

(4).

One small study found

to be inferior to placebo after
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one year of use

(142).

Another serious limitation to the usefulness of these agents
is the associated side effects.

Undesirable side effects re¬

semble those found with use of the prototype drug,

amphetamine:

central nervous stimulation effects - restlessness, anxiety,
insomnia, and similar symptoms manifested in extreme by psychosis
cardiovascular effects - including headache,
cardiac arrhythmias,
excessive sweating;

palpitation and

angina, and other less common problems;
gastrointestinal effects-dry mouth, metallic

taste, nausea, vomiting,

abdominal cramps and alas, anorexia

may be troublesome for those that are compensatory eaters

(143).

Psychic dependence and habituation are also associated with
amphetamine abuse,

and the antidepressant effects of these

drugs add to their abuse potential.
Although the amphetamine anorexiants generally have similar
actions,

differences in effectiveness and side effects have

been claimed.

Amphetamine-like drugs used in the United States

for appetite suppression include:

1) amphetamine
6) diethylproprion(Tenuate,Tepanil)
2) methamphetamine
7) phenmetrazine (Preludin)
3) benzphetamine (Didrex) 8) phendimetrazine(Dietrol,Plegine)
4) phentermine (Ionamin,
Welpo)
9) mazindol (Sanorex)
5) chlorphentermine
(Pre—Sate) 10) clortermine(Voranil)
11)fenfluramine (Pondimin)

Although comparative studies show some advantage of diethylproprion in terms of side effects

(29)»

the advantages of the
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newer agents over amphetamine is not satisfactorily proven (143):
Fenfluramine is a promising agent,

causing drowsiness rather

than restlessness and insomnia and is said to have a lower
abuse potential

(143,

144).

Because of their short duration of effectiveness the anorexiants can be used in several ways in a dietary program.
dock lists the following indications:

1)

to enable patient to

maintain diet after initial motivation wanes;
depressed patients from the beginning;
help lose relapse weight;

4)

Crad¬

2)

to help certain

3) short courses to

diet failures

(29).

This reasonable

and flexible approach emphasizes that these agents can be of
use in a dietary program,

but cannot be relied upon as the

major contributor in weight reduction.

Not only must the phy¬

sician be sensitive to the fact that these agents have unde¬
sirable side effects and abuse potential, but that this form of
treatment by itself offers the patient little in terms

of long

term weight control.
Other appetite suppressants have been used.
glycemic biguanide,,

The oral hypo¬

phenforrnin (DBI), has enjoyed some use

for obese maturity-onset diabetics.

Its purported success may

result from its mechanism of action that lowers blood sugar
without increasing endogenous or exogenous insulin,
a result of its side effects of ketosis, nausea,
taste

(143).

effects,

or may be

and metallic

In view of numerous contraindications and side

phenforrnin is a difficult drug to use and thus not
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prescribed by many clinicians.

Digitalis has been misused for

weight reduction (147), anorexia being one toxic manifestation
among other life-threatening ones.

Its use for the treat¬

ment of obesity is irresponsible.

The treatment of obesity by hormones has maintained theore¬
tical appeal based upon the suspicion or even conviction by
many that obesity is fundamentally an abnormal metabolic and
regulatory state.
tion,

Thyroid hormone has received the most atten¬

its use in obesity based upon the increased caloric

utilization affected by the hormone.

Contrary to the opinion

of many obese persons, the thyroid status in obesity is not
different from the normal
within normal limits
been reported,
of hormone
146).

(148-151)

(152).

and the metabolic rate is

Abnormal thyroid function has

finding that some obese have altered binding

(131),

and have reduced clearance of T^ and T^ (145,

Numerous studies over the last forty years have demon¬

strated that thyroid hormone can potentiate weight loss
124).

(153-159,

However, follow-up studies indicate that the losses are

not maintained after the drug is stopped

(158-159)*

This ten¬

dency to regain weight quickly is not well understood, but pos¬
tulated mechanisms include a continuance of increased appetite
and bad eating habits which were developed during the hypermetabolic medicated state,

or a decrease in physical activity

secondary to fatigue and a temporary hypothyroidism after dis¬
continuance of the hormone

(160).

Another drawback of the
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thyroid hormone induced weight loss is that much of the loss
is from lean body mass.

Bray found about one-fifth of thyroid

induced weight loss to be from adipose tissue stores

(151).

The negative nitrogen balance can be controlled by the use of
steroids

(l6l)

or by increased protein intake

(162),

method being far more, preferable for these patients.

the latter
The

greatest concern for the use of thyroid hormone lies with the
cardiovascular side effects.

Palpitations, tachycardia,

increased blood pressure are common effects
cardiomegaly may occur (163)

(158,

and

159, 151,157);

and angina pectoris has been re¬

ported in twenty per cent of one group studied

(157).

losses of calcium (164) may also be troublesome,

Urinary

possibly precip

itating osteoporosis.
In sum,

thyroid hormone can be used in a dieting program to

produce greater weight loss,

is of doubtful benefit in the long¬

term maintenance of weight control,

and is associated with a

number of troublesome and potentially dangerous side effects.
Consensus opinion (165) and recent review (160)

conclude that

the use of thyroid hormone in the obese ought to be limited to
those patients found to be hypothyroid.

However, Bray claims

that thyroid hormone can be used effectively.

Using 100 mg of

triiodothyronine daily, he found an increased metabolic rate
without the extent of the untoward effects found when
or more hormone have been used

(158).

150 mg

A high protein diet can

reduce the problem of nitrogen imbalance.
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Other hormones have been used.

Human chorionic gonadotropin

(HCG) Has received some attention since Simeons first reported
its use in 1954 (166).

However,

that study has been criti¬

cized and subsequent trials including double-blind studies found
HCG to be of no benefit in weight reduction

(167,168,169).

Interest has been rekindled following a recent report by Asher
and Harper who administered 125U of HCG by daily injections in
dieting patients for six weeks and found a significantly greater
weight loss in those patients than in a placebo control group
(170).

However, Hirsch and Van Itallie have

challenged the

conclusions of this study, noting that the HCG group received
more injections than the control group due to a greater drop¬
out rate in the latter group.

They reason that the HCG group

may have benefitted from the placebo effect of greater injection
therapy (171).

Although the mechanism of action for HCG in

weight reduction is undetermined,
tion of mood

(172),

prevention of hunger,

eleva¬

and thyroid stimulating activity (173»

have all been postulated.

17*0

The burden of proof remains to est¬

ablish the effectiveness of HCG,

and,

although it appears to be

a safe agent thus far, its use should be considered experimental.
Growth hormone

(GH)

is known to mobilize fatty acids,

deplete fat stores without significant nitrogen loss,

to

and re¬

ported to have a calorigenic effect through increased oxygen
consumption (175,

176, 143).

These actions attract theoretical

interest for the use of GH in obesity.

bray administered 5 mg

of GH daily to patients receiving tri-iodothyronine and found
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oxygen consumption greater, nitrogen loss less, but weight
loss slower than in the group receiving tri-iodthyronine without
GM (l6l).

Growth hormone appears to be well tolerated for short

term usage, but long term safety (diabetogenic effect?) and
effectiveness are undetermined.

The present status of GH

remains theoretical, as very limited supplies limit its use to
restricted therapeutic trials (143).
Finally,

it should be mentioned that progesterone has

been found to be of some benefit for the Pickwickian syndrome
(177).

The mechanism involved is not known,

but believed to be

related to pulmonary function, not weight (178).

No longer used

for weight reduction is the metabolic stimulant dinitrophenoi
(DNP).

This compound interrupts the coupling of oxidation and

phosphorylation,

causing generation and dissipation of heat

rather than the formation of energy-rich phosphates.

Use of DNP

can raise the metabolic rate to about +$0fo and keep it at that
level as long as the drug is continued.

However,

acute toxic

effects related to hyperthermia are a hazard, as are a wide
spectrum of untoward reactions associated with chronic admini¬
stration of DNP.

Because of the high incidence of toxic reac¬

tions and abuse of DNP, the drug is no longer used for therapy(143).

The use of drugs in the treatment of obesity remains of
undramatic benefit.

Amphetamines and thyroid hormones are the

only agents that can be used reasonably in a weight reduction
program.

Utilized as adjuncts to a good diet, these agents must
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be used with care in an individualized program that takes into
account risks and benefits.

Although there is some evidence

that small dosages of thyroid hormone can potentiate the action
of amphetamines (179*180), these studies are inconclusive becaus
of the short duration of patient follow-up.

Follow-up studies

tend to indicate a somewhat favorable result of drug therapy
as compared to only diet therapy when the follow-up time is
short (181) and unfavorable results when follow-up time is
longer.(182),

The benefit of placebo effect need be antici¬

pated by the physician, and initial successes ought to be put
in the context of treatment risk and long term benefits.

Psychotherapy and Groups

Hilde Bruch has pointed out that obesity is associated with
a number of psychological disorders rather than one (14).

In

light of this and in understanding the complex non-psychological aspects of the etiology of obesity, the idea of a psycho¬
therapeutic cure for obesity seems unlikely.

However, there is

probably a group of patients in which emotional maladjustment
is central to their obesity.

Bruch has described in these pa¬

tients a positive relationship between food intake and conflict
situations.

The obesity may either be chronic, in which case

it has become part of personality development, or may be acute,
a reaction to a precipitating stress.

A careful psychiatric

and social history will often uncover associated emotional
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problems.

As mentioned before, a strong relationship between

physician and patient can be of great therapeutic importance,
and appropriate support,
psychotherapeutic value.

understanding, and firmness has
More serious emotional problems may

require considerable time and pschotherapeutic skills, necess¬
itating referral to the specialist.

Often such patients are

identified only after treatment failure or development of
"dieting depression".

(183).

Psychotherapy is a therapeutic

modality that some patients unequivocally refuse, while other
more willing patients may find the expense difficult.

The use

of psychotropic drugs may be appropriate for some patients.
Because this approach is so individualized, both diagnostically
and therapeutically,

analysis of results is not practical.

Feinstein found psychotherapy and "mood elevation"
for individualized cases,
ance

(3).

successful

and possibly of benefit for mainten¬

Clearly, some obese patients cannot successfully lose

weight v/ithout adequate counseling and may in fact find dieting
a severe upset to their emotional homeostasis.

Of greater interest than individual psychotherapy in the
treatment of simple obesity is group therapy.

The effectiveness

of group therapy-like methods is widely represented by the
popular private lay organizations,

the so-called self-help groups,

that claim a high degree of success in treating obesity.

Rigor¬

ous analysis of methods and results are scantily represented in
the literature for these organizations.

TOPS

(Take Off Pounds
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Sensibly),

a non-profit group operating within a model not

unlike Alcoholics Anonymous,
venture,

and Weight Watchers, a commercial

are the largest of these organizations.

smaller groups exist,

A number of

some of which have been transiently

successful commercial ventures in recent years

(184).

Although the profit-making groups are generally unwilling
to allow impartial researchers to study their results,

there

are several reports on the non-profit TOPS

Stunkard

(185*186).

reported in 1970 that TOPS had well over a quarter of a million
members in some 9500 chapters across the country.

In his study

of 485 members in 22 chapters in the Philadelphia area,

he

found membership to be comprised predominantly of white middle
class women,

aged 40 to

60, averaging about 60% above ideal

body weight, and retaining active membership for an average
l6| months.
pounds,

The results were impressive.

28% lost more than 20

a figure that compares well with the medical litera¬

ture on weight reduction (2).
successful chapters,

When considering only the 5 most

50/6 lost at least 20 pounds, which is as

good a result as the very best reports in the medical literature.
The TOPS results also fared well when considered for 40 pound
loss and by the criterion of reduction index (102).

Follow-up

reports are lacking, but one would expect that a treatment moda¬
lity that is social in nature,

and realtively non-episodic in

approach would stand a greater chance of long-term success
than would many other methods.

Questions remain, however,

make it difficult to interpret Stunkard*s results.

that

Might not
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this population be an unrepresentative group of obese indi¬
viduals, evidence by it being middle class,
motivated enough to seek out the method

99% female,

and

(only yfo joined based

upon physician's recommendation)?
Other reports on the self-help groups have appeared.
Failures were reported by Bowser, who found group therapy no
better than non-treatment control in his subjects

(187)#

and

Sussman, who reported a greater than 90% attrition rate over
6 months within a group studied

(188).

Equally represented

were a number of positive reports of group therapy (189»190).
The fundamental aspect of the self-help approach is the
use of social and peer group pressure to establish a positive
attitude towards weight loss and a negative attitude towards
rule-breaking and weight gain.

By becoming part of the group

(which usually meets weekly)

a new social motivation to reduce

is created.

Often,

the weigh-in opens each meeting in a highly

ritualistic manner.

Also important is the education and use of

a planned but flexible diet that is rarely unduly harsh,

allow¬

ing liberal amounts of food and emphasizing good food choice
and reduced portions of richer foods.

It allows the dieter to

feel that he is not being calorically restricted
he is)

(but of course,

and avoids the frequent association made between dieting

and punishment.

Discussion and sharing of relevant anecdotes

can be useful, as motivation is intimately connected with group
sharing and spirit.

As a treatment for obesity,

these groups
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are less expensive than methods that require significant phy¬
sician time, and also have the appeal of offering a method for
long-term weight control through establishing good dietary
habits and attitudes.

They should be among the physician's

possible alternatives for the treatment of obesity.

Behavior Modification

One of the more promising methods for the treatment of
obesity to gain recent attention not unrealated to the selfhelp groups is that of behavior modification.

Based upon the

basic psychological premise that views behavior in a stimulusresponse model,

behavior modifiers see obesity as the result

of an eating disorder which can be behaviorally manipulated.
Behaviorists look at the poor long term results of other obesity
out-patient therapies

(2)

and conclude that diet and drugs fail

because patients lapse back into their former habits

(100).

Obesity is viewed as an addictive behavior disorder,

like al¬

coholism and drug addiction (97)»

in which eating provides posi¬

tive reinforcement through good taste,
iety or depression reduction.

hunger relief,

and anx¬

A number of behavior modification

systems designed to reduce caloric intake have been described
(191-197).

In the medical community Albert Stunkard has emerged

as the chief spokesman for behavior modification for obesity.
He described this approach in four stages:
1-Description of the behavior to be controlled.

Daily
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records by patients of amount, time, circumstances of eating:
increased awareness of quantity, speed, environmental and
psychological situations associated with eating.
2- Modification and control of the discriminative stimuli
governing eating.

For example, time and places have become

discriminative stimuli signaling eating.
the stimuli come to "control" behavior.

As in animal behavior,
To decrease the potency

of discriminative stimuli patients are encouraged to confine
eating to one place (kitchen), to use distinctive table settings,
and to make eating a "pure" experience (no other activities or
distractions permitted.)
3- Development of techniques to control the act of eating.
Specific techniques to decrease eating speed, become aware of
components of eating process, and gain control (e.g.

counting

mouthfuls, replacing utensils onto table after mouthfuls,
deliberate interruptions).
4- Prompt positive reinforcement of behaviors that delay or
control eating.

Reinforcement schedule, point system, money

(as donations to altruistic cause).

No berating for failure (183).

This technique for the treatment of obesity was first
reported in 1962 by Charles Ferster, a student of B. F. Skinner
(198).

Interest was lacking until 1967, when Richard Stuart's

paper appeared (195).

Over the next seven years, Stunkard claims

about ten reports appeared in the literature.

He notes:"...this

field has grown up largely outside of medical purview and, at
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times, in the face of medical oppostions." (183) Stuart, a
social worker, used behavior modification over a year and re¬
ported a greater than 20 poung weight loss for all group mem¬
bers (195)•

Although a small and uncontrolled study, the results

are noteworthy in that they represent the best ever reported
for outpatient treatment and by a method conducted by a man
without any experience with obesity (183).

Harris followed with

a study using mildly obese college students, finding highly
significant losses in the behavior modification group as com¬
pared to a control (19*0 » "but the study has been criticized
for using as controls students who were told they were on the
waiting list for treatment (183).
better controlled.

Wollersheim’s study is

Using 79 mildly overweight female college

students, 4 groups of 5 members each, experienced one group
treatment modality:

1-focal behavior modification; 2-non-specific,

insight oriented;

3-social pressure/self-help-like TOPS; 4-de-

ferred treatment.

Behavior modification was superior to control

groups (197).

Hagen, with a similar population, ran ten sessions

for several months with a therapist-run behavior modification
group, a leaderless bibliotherapy group in which a behavior modi¬
fication manual was used, and a deferred treatment control.
The manual and group therapy members did equally well, averaging
a 12 pound weght loss (199).
Unlike the above studies, Stunkard's patients averaged 80%
overweight (191).

He compared the results of behavior modifica¬

tion groups led by young therapists who were leading such groups
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for the first time, to matched groups led by an experienced
clinician with extensive experience in the treatment of
obesity, Dr. Sydnor Penick, who used traditional methods of
supportive psychotherapy, instruction in dieting and nutrition,
and, upon demand, appetite suppressants.

Not only did the behav¬

ior modification groups do better after 12 weeks of treatment
for both cohorts, but one year follow-up also showed that
patients at least maintained their losses.
that Dr.

It is noteworthy

Penick*s patients did impressively at one year follow-up.

Percent of groups losing specified amounts of weight (from Stunkard)
Behavior modification
groups (No.=15)
Weight
Loss
(lbs.)

1-year
After
treatment follow-up

~74o~
730
720

13
33
53

33
40
53

Control therapy
groups (No.=17)
After
treatment
0
0
24

1-year
follow-up

Ave. in medi¬
cal literature
at end of
treatment
(2)

12
29
47

-n
-

25

Recently, Brightwell summarized a behavior modification
technique that he considered practical for the general physi¬
cian (200).

He lists four criteria for patient selection:

1- 10-100# overweight? 2-desire to lose weight; 3-motivation to
participate over an extended period; 4—absence of emotional or
physical contraindications to weight loss.

He recommends five

twenty minute sessions over two to three weeks, then one session
per month for follow-up, and reports good results for his group.
"Such programs help patients learn how to eat properly and sake
responsibility for their intake".

(200). Behavior modification
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appears to be a superior outpatient method for weight reduction
for the mildly and moderately obese.

It is safe, relatively

inexpensive and efficient, and in theory conducive to long
term success.

Massive Obesity and Radical Treatment Methods

Based upon changing dietary habits, with or without the
use of adjuncts, the reasonable treatment approaches discussed
thus far, with the possible exception of thyroid hormone, ought
to be viewed as relatively conservative in nature.
radical weight reducing methods also exist.

Several

The appropriate use

as opposed to potential misuse of these methods is among the
most profound challenges in contemporary medicine.

It is at thi

point that the clinician must consider the entity of massive or
morbid obesity as distinct from mild or moderate obesity.

Patho

physiologically such a distinction may seem artificial, but
clinical realities call for this type of diagnostic maneuvering,
even if dividing lines are admittedly somewhat arbitrary.

Bray

warns:
Radical methods should be employed only in mas¬
sively obese patients who are severely handicapped
or physically disabled by the excess weight, and
only then after failure of all conservative
treatment. (21)
Craddock categorizes as intractably obese those patients
whose obesity is "resistant to normal methods of treatment by
diet and drugs".

(29)

He notes that this state is commonly
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associated with compensatory eating and, simplistically, in a
cycle of unhappiness/love lack->eats-^fat-*unhappiness.

Em¬

phasizing the importance of uncovering patients’ reasons for
overeating and attitudes towards dieting, Craddock states that
depression should he appropriately treated.
The morbidly obese patient has been defined as:
...one who has reached two or three or more times
his ideal weight, who has maintained this level for
five years or more despite efforts by himself,
his family, and his physician to bring about effec¬
tive and sustained reduction of weight to accept¬
able medical standards.
(201)
A less exacting criterion commonly used for morbid/massive
obesity is weighing greater than 100 pounds above ideal v/eight.
Refractoriness to nonradical methods may have more than a merely
etiologic foundation.

These methods can at best reverse caloric

balance to the point of a maximum adipose tissue loss of about
two pounds per week and probably less because of metabolic adapta
tion in these patients.

This rate of weight loss in a patient

more than 100 pounds overweight is frustratingly slow and will
rarely supply the positive feedback to maintain sufficient
motivation to override the emotional and physical challenge of
decreased eating.

A recent editorial explains:

"For the morbid¬

ly obese, 40 pounds is about the most weight that is lost and
95$ of these patients will return to their previous or a higher
weight within two years."

(202).

The following questions need

be considered when evaluating the severity of obesity and appro-
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priateness of radical therapy:
1)

How obese does the patient measure?

2)

How severe are the acute and chronic health con¬

sequences of the obesity?
3)
treatment?

What are the chances of success of conservative
(Consider weight and treatment history, psychosocial

factors, motivation and interest).
4)

Do the benefits of reduction outweigh the risk

of treatment?

Fasting

Physiologically, the concept of fasting is likely as old
as that of diet.

Anthropologically, the difference is great, as

fasting since ancient to modern times has represented bodily
self-sacrifice for some higher spiritual good.

Willful starva¬

tion other than of the obsessional martyrdom type is seen by
the medical community in patients, usually young women, with
the bizarre eating disorder, anorexia nervosa.

However, for the

obese, fasting can maximize a negative caloric balance and
has therefore been used therapeutically for obesity.
Bloom first reported fasting as an introduction to obesity
treatment in 1959* when he hospitalized nine patients and
fasted them for four to nine days

(203).

After an average loss

of 2.6pounds per day - greater than accountable based upon
caloric deficit alone - these patients were put on low calorie
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diets as outpatients.

After two to nine months, follow-up

results were satisfactory.

Bloom emphasizes that the fast's

benefit was largely in terms of patient education, his pa¬
tients learning that:

1-they could lose weight; 2-they did

have will power; 3-food causes obesity; 4-they could tolerate
a reducing diet; 5-th.ey could feel well when fasting.
Keys had earlier described in his work on human starva¬
tion the absence of excessive hunger in fasting (204).

The

appeal of a treatment that dropped weight more quickly than
dieting and could preclude the hunger problem began to at¬
tract other clinicians.

In i960 Duncan fasted fifty intractably

obese subjects for four of fourteen days, achieving an average
daily weight loss of 2.5 pounds (205).
given.

Vitamins and fluids were

He noted anorexia beginning after one day of fasting,

proportional to ketonemia, and reports his patients had a sense
of well-being while fasting.

Also noting improved patient morale

after the fast, he planned weight maintenance by using inter¬
mittent short fats to prevent relapse, allowing his patients
to eat freely between fasts.
Thomson reported that fasting could be effective and well
tolerated for longer periods of time as in the case of one of
his patients losing ninety-seven pounds in 236 days (206).

He

concluded that fasting is the treatment of choice for gross
obesity.

Eleven of Drenick’s patients fasted as outpatients

for twelve to one hundred and seventeen days, registering an
average daily loss of 0.91 pounds (207).

These patients weighed
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from 240 to 550 pounds and all had medical problems.

Six

stopped fasting before 25days because of side effects or
choosing to drop out.

The average loss was about 30 pounds,

the greatest 116 pounds, and initial losses were rapid (up to
nine pounds in one day) and found to be proportional to ini¬
tial weight.

Drenick comments that the starvation v/as well-

tolerated and contributed to these outpatients' eating habits
in the future.
Several follow-up studies help us to evaluate the long¬
term usefulness of fasting.

Hunscher's large study followed up

709 of Duncan's hospitalized fasted patients with a history
of intractable obesity who were put on a reduced caloric diet
and instructed to fast one day per week (208).

Only 50% re¬

sponded to the follow-up inquiry and of those that did, 46%
lost weight, 21% stayed the same, and 33% gained since hospi¬
tal discharge.

The massively obese were among the most success¬

ful in the study.

Hunscher concludes that two-thirds of the

responders, known to be treatment failures, had benefitted from
the fasting regimen.

However, it would be unwise to assume

that the 50% who did not respond did as well as the other
group, and all that is knov/n is that 23% lost weight, and 33%
did not gain weight.

Also of note was that 58% of the re¬

sponders had follow-up durations of less than one year, where
as 93% of the non-responders had follow-up periods greater
than one year.

Harrison followed-up 62 patients v/ho had had a

hospital stay of 10 days (209).

Of those one year post-fast, 40%
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lost weight, while Zb% of the two year follow-up group had
lost weight.

Fifteen patients had been fasted more than once,

but did not show significantly better results.
smaller study is more discouraging (210).
greater than

McCuish's

Twenty-five patients

overweight with a history of treatment failure

were followed-up a mean fourteen months after a successful
inpatient fast for an average 25 days.

All patients gained

weight, the average amount of 28.5 pounds being slightly
greater than the average amount lost by fasting.

Because

of these poor results, McCuish recommends using fasting only
when some other medical reason necessitates it.
Fasting has been considered a radical method for obesity
treatment because it is nutritionally drastic.

Numerous

physiological changes have been noted in these therapeutical¬
ly starved patients, sometimes of significant clinical nature.
Total starvation leads to an unavoidable protein depletion (21).
Although not reported as a serious state, arrested hair growth,
mild anemia and neutropenia as well as skin drying and scaling
can occur.

Ketonemia and ketonuria will occur, and can be

used as a check for fasting adherence.

Although usually mild,

symptoms of unpleasant taste and nausea are not uncommon, and
are thought by some to result in the hunger lack noted during
fasting.

The decreased hunger theory has been challenged,

however, as Silverstone explains that what actually occurs
is an increased hunger over the first fast day followed by a
normal hunger state (211).

Serum lactate levels may also be

/

elevated and one case of fatal lactic acidosis during fasting
has been reported (212).

Besides protein loss, fluid losses

can also be marked, particularly early in the fast.

Ball

determined that for a sixteen day fast less than ±5% of the
weight loss was fat as compared to 70% when weight was lost
by using a calorie-restricted diet (213).

More prolonged fasts

burn a greater percentage of fat, and analysis has determined
that between 2000 and 2500 calories are lost per day (214).
Reported weight losses for fasters reflect the effect of early
fluid losses: 2.5 pounds average loss per day for short fasts
(one to two weeks)

(203*205*209) versus closer to one pound

average loss for longer fasts (207,206,210).

Fluid losses con¬

tribute to hypotension - orthostatic dizziness is a common
minor problem-, decreased glomerular filtration (increased
serum creatinine), and decreased hepatic perfusion (increased
BSP retention and serum bilirubin)

(21).

Potassium depletion can also be a clinical danger, and sup¬
plementary potassium chloride is recommended (21).

Magnesium,

calcium, and phosphorous are also in negative balance, but the
depletion seems to be insignificant.

Hyperuricemia commonly

occurs in which case allopurinol or probenecid can be used.
Blood sugar usually declines slowly, and may be as low as 40mg^,
but symptoms are not reported to have occurred (21).

Vitamins

are needed, and one case of Wernicke's encephalopathy has been
reported (215).

Other problems include lassitude and weakness,

constipation and, for some, a psychological reaction to fasting.
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Exercise should be limited, as weakness, orthostatic hypotension,
and cardiac arrhythmias may occur.
'TABLE 6*

Recommended lie a ic at ions and Tests During
prolonged Fasting.
(From Bray (21) )

Routine
Laxatives first 3 days
Allopurinol 600 mg/day
Vitamin and mineral capsule, l/day
Folic acid, 5 mg/day
Bicarbonate of soda, 1 g/day
Potassium chloride solution (sugarless), 2 g/day
As Necessary
Calcium carbonate or antihistamines for nausea
Mouthwash or calorie-free chewing gum for bad-taste
Soluble bath oil for dry skin
Tests
Blood pressure, recumbent and upright, daily
Urine acetone (ketone reagent strip), daily
Serum creatinine, weekly
Serum uric acid, weekly

Bray recommends that fasting not be continued for more than
two months, as some side effects are more evident as the star¬
vation is prolonged (21).

Long-term effects from the metabolic

changes of fasting are yet unknown.

Contraindications to fast¬

ing mostly follow logically from the observed metabolic changes
and the nutritional consequences of starvation: pregnancy,
peptic ulcer, hepatic insuffiency, labile diabetes mellitus,
gout or hyperuricemia.

General mental and physical health must

be considered, and the importance of heart disease is indicated
by the report of two deaths in fasters with left ventricu¬
lar failure (216).

Refeeding after fast is best gradual.

retention may be marked, and a post-fast weight gain should
be expected.

Salt restriction may be beneficial.

Fluid

-70-

It has been suggested that perhaps some of the metabolic
derangements and dangers of fasting could be avoided with the
use of a semi-starvation regimen.

Genuth found a lessening

of hypoglycemia, ketosis, hyperuricemia, and urinary losses
of potassium and phosphorous by adding to the fast only 50
grams per day of L-alanine, a glucose precursor (217).

He also

reports a persistence of anorexia when L-alanine, glucose,
or casein calcium (milk protein) are used for 200 to 300 calories
per day.

In a program for 75 massively obese patients (average

196$ ideal weight), Genuth followed a completely foodless week
of hospitalization with a semistarvation regimen consisting of
45 grams of casein calcium (Casec) and 30 grams of glucose
daily for eight to fifty weeks as outpatients with close mon¬
itoring (218).

Protein sparing through the use of small a-

mounts of exogenous protein had been previously documented
(219,220), and daily casein had been used in fasrers who con¬
tinued to lose weight but maintained nitrogen balance (220).
60$ of Genuth's patients lost 40 pounds or more, the average
loss being 85 pounds.
week.

Losses averaged about four pounds per

37/& of the patients were defined as failures:

did not

last eight weeks or did not average two pounds per week loss.
Most failures had vague symptoms from the withdrawal of food.
No severe chemical derangements occurred, and a modest cata¬
bolic state with small potassium and phosphorous losses did
not prevent patients from having normal activities.

Uric acid
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and B-hydroxybutyrate elevations were measured but were well
below fasting levels.

Fasting is an effective method for relatively rapid weight
loss.

After careful initial screening to exclude those pa¬

tients for whom the physiologic stress of starvation would be
dangerous, an inpatient fasting regimen can be well tolerated
if close medical monitoring and appropriate preventive treat¬
ment are provided.

Minor complaints are common, and life-

threatening problems are uncommon but do occur.

The contri¬

bution fasting makes to long-term obesity management is still
uncertain, but most studies indicate modest long-term benefit
for the intractably obese.

Outpatient fasting as a method

more reasonable than periodic inpatient fasting is not ideal
because of the looser patient supervision and the marked fluid
and protein shifts associated with the onset of fasting.

Low

protein/glucose semistarvation regimens appear promising and
may prove useful and relatively safe for a segment of the mass¬
ively obese outpatient population that can comply with the
freedom of an outpatient regimen.

In sum, fasting may be

indicated for the massively obese, the intractably obese, or the
obese patient v/ho requires a rapid v/eight loss for medical
reasons.

It is of best use for rapid weight loss and of less

clear benefit for long-term management.

If time permits, apro-

priate patients may be better treated with outpatient semi¬
starvation.

As always, risks of this radical treatment must be
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weighed against expected benefits.

Surgery

Obesity can be a chronic disorder, refractory to medical
treatment, and particularly when massive, may be clearly
life-threatening.

Surgery as a last resort to produce a

negative caloric balance and maintain v/eight control may be appro¬
priate for some patients as indicated by the opinion stated in a
recent editorial:

"There is no satisfactory nonoperative

treatment for morbid obesity."

(202).

The intestinal bypass

has been the surgical procedure to receive the greatest atten¬
tion, the basic principle being that of decreased nutrient
absorption due to a surgically reduced intestinal absorp¬
tive surface.

Kremen's experimental report of jejunoileostomy

appeared in 195^ (221), and was soon followed by Payne's series
of 90% bypass jejunocdtostomies

(222).

Although fine weight

losses were achieved, the morbidity was prohibitive, as severe
diarrhea, electrolyte abnormalities, and liver pathology v/ere
seen and one death was reported.

Reanastomosis in a second

surgical procedure was recommended.

By the mid - 60's the

medical community had denounced the bypass as an unsafe approach
to obesity (223).

Nevertheless, some surgery continued to be

done, reports appeared, experience was gained, and techniques
improved (224 - 230).

The jejunoileostomy emerged as the
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best procedure, a less radical bypass that could achieve a
balance between intake and weight loss v/ithout the need of a
second surgical procedure.

Recent articles estimate that about

1000 cases have been published in more than two dozen series
and the the total bypasses performed is probably several times
this figure (229»230).

The most popular procedure is that

developed by Payne and DeWind (225) in which an end to side
anastomosis is made between 14 inches of jejunum proximally
and the last 4 inches of terminal ileum distally, allowing for
some ileal absorption and leaving the ileo-cecal valve intact.
The bypassed intestinal segment remains in situ closed at the
jejunal end, and may be involved in the variable absorption
seen, as a result of ileal reflux.
developed with some good' results.

Modifications have been
The end to end jejunoil-

eostomy is claimed theoretically good for lowering hyperlipidemia
(225), and has also been reported to produce better weight loss
than the end to side procedure (231).
Postoperatively an adaptation period occurs in v/hich the
remaining absorptive intestinal surface hypertrophies and weight
eventually levels off at a point somewhat above the ideal.
V/eight losses for the first year are generally reported to be
between 85 and 100 pounds, greatest during the first six months,
and proportional to the initial weight (231, 21, 229, 232).
represents about a 30% v/eight loss.

Second year losses are

reported to average about 50 pounds; third year average about
25 pounds, and one study found an average nine pounds lost

This
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during a fourth postoperative year (231).

Buchwald averaged

the weight losses reported in nine series and found jejunoileostorny produced 35% weight loss (follow-up times varied, though)
as compared to 4l% weight loss for a small series of jejunocolostomies

(225).

Salmon reports that two-thirds of his patients

plateaued at weights within twenty pounds of ideal at one to
three years follow-up (228), while Buchwald reports that 90% of
his 94 patients reached within 50 pounds of their ideal weight
(230).

A few patients will not successfully lose an adequate

amount, varying from one series to another (228,229).

Bray notes

that the weight loss in bypass patients is slightly slower than
that achieved by fasting (21),
The evident success in losing and maintaining weight for
the massively obese patient with the intestinal bypass must be
measured against the morbidity and mortality that results from
this procedure.

Operative and early postoperative mortality

has been variously reported between 0.7% and 6% for a number
of the larger series (225, 228, 230, 222, 202), as pulmonary
emboli, cardiac failure, myocardial infarction, and wound in¬
fections are most commonly involved.

Payne, who reports on

I65 of his patients operated on over a 16 year span, found a
total mortality of 9.7%, but only 6% that could be attri¬
buted to the bypass, with hepatic failure as the most common
cause (222).
The side effects of intestinal bypass are considerable.
The average postoperative hospital stay was 10.5 days in one large
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series, and non-fatal surgical complications of wound pro¬
blems, upper gastrointestinal bleed, urinary tract infection,
pulmonary embolus, thrombophlebitis, and pneumonitis are re¬
ported in a minority of patients

(230).

Longer term effects

experienced by nearly all patients include diarrhea, electrolyte
abnormalities, and deficient vitamin B12 absorption.

The diar¬

rhea tends to taper off after a 3 to 6 month period during
which nearly every patient experiences the troublesome symptom,
with up to 30 liquid stools per day reported (229).

Related

problems of anal pain, hemorrhoids, proctitis, and fissures
can make this a difficult period.

Salmon reports that 39% of

his patients had diarrhea (3 liquid stools per day) at 6 months,
25% at one year, and 13% at two years
can help, as can antidiarrheal agents.

(228).

Special diets

Although the diarrhea is

usually controlled v/ith time, dietary indiscretion may cause
recurrence. - Hypokalemia and hypocalcemia are frequent in the
early postoperative period, when absorption is very low.

One

hypocalcemic death has been reported and another series reported
hypocalcemic tetany in 3 of 140 cases (230).

Prophylactic

therapy using Lomotil, calcium carbonate, potassium, multi¬
vitamins, and B12 injections has been recommended (229).

Fa¬

tigue, thirst, nausea, abdominal pain, and small gastrointes¬
tinal bleeds seen in the early postoperative period are usually
well controlled.

Hair loss occurs in about 3%» but recovery is

after several months.

A number of long-term complications exist.

Of greatest

interest has been the effect of bypass on the liver.

Reports

of hepatic failure and death (225) led to the conclusion that
the bypass produces liver disease and is more hazardous than
anticipated (233)«

However, it was noted that it had previously

been determined that liver function was abnormal in massive
obesity (23^) and that 75% of the patients undergoing bypasses
have fatty livers preoperatively (235)•

Postoperatively, fat¬

ty changes are variable and unpredictable (222).

A recent study

reports that twelve of eighteen patients had an elevated SGOT
and biopsy proven worsened fatty liver four months postopera¬
tively, and also showed amino acid deficiencies in a profile
typical of protein-calorie malnutrition.

Between 12 and 36

months postoperatively weight stabilized, SGOT returned to nor¬
mal, hepatic fat diminished, and amino acids improved, all,
presumedly, as a result of increased intestinal absorption (236).
Post-operative amino acid supplementation is proposed as a
means to protect the liver.

Evidence supports the fact that

after a period of postoperative challenge, the liver goes on
to improve and may be improved from its preoperative state
(237,236).
Other long-term complications include those that can re¬
sult from the intestinal surgery: adhesions, obstruction, and
rarely intussusception.
may be severe (230).

Polyarthritis has been reported, and

As with fasting, gout and hypotension
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may be precipitated.

Other hazards include renal calculi, ,

gastric stress ulcers, duodenal ulcers, cholelithiasis, and a
hyperchloremic acidosis with renal impairment.

Intractable

nausea and vomitting can be severe, leading to malnutrition and
electrolyte imbalance.

If a complication is severe enough and

potentially reversible, reanastomosis may be indicated, as
Payne found it necessary to reanastomose four of 153 jejunoileostomies because of intractable electrolyte imbalance and severe
liver changes (231).
The risks and ill effects of intestinal bypass are im¬
pressive.

Indications and contraindications for this surgery

are generally cautiously expressed v/ith this in mind.

The

following include criteria for surgery usually mentioned:
1-massive obesity, usually of long duration; 2-a history of
multi-treatment failure; 3-medical complications of obesity;
4-emotional stability, cooperation, and motivation; 5-full
informed consent.

The last item is of great importance, as

patients must understand what risks and responsibilities
they are taking.

An experienced and available medical and

surgical team might be added to the criteria list, as the long¬
term responsibilities of the providers are considerable.
Contraindications are relative, but in general reflect an
attempt to protect the highest risk group from the hazards of
the bypass.

Often mentioned are liver abnormalities, advanced

age, emotional instability, hostility, unwillingness to stop
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all alcoholic intake, unrealistic expectations, and condi¬
tions that would be too risky for a major surgical procedure.
The primary benefit of intestinal bypass is irreversible
weight loss and weight control.

Related benefits are decreased

blood pressure (75%° preoperatively are hypertensive (230),)
improved respiratory and cardiovascular function, limitation
of diabetes mellitus (Q% preoperatively diabetic), improved
arthritis, improved fertility, decreased serum cholesterol,
and improved psychological situation.

The weight loss is also

beneficial against other obesity hazards that may now be pre¬
vented.

Solow examined the psychological effects of intestinal

bypass by studying 24 patients who had had the operation (238).
Improvement in mood, self-esteem, interpersonal and vocation¬
al effectiveness, body image and activity levels were found,
and the decrease in depression and improvements in ego strength
were directly proportional to the magnitude of weight loss.

Appropriate use of the intestinal bypass for obese patients
is a great challenge.

In making this decision the following

questions may be helpful in the context of risk-benefit model:
1-

How obese is the patient?

2-

How great is the debilitation or risk caused by obesity?

3-

Have other methods been given an adequate trial?

4-

Is he a good candidate in terms of the physical and
mental stresses of this procedure?

There clearly seems to be a population of massively obese
patients for which the intestinal bypass is the treatment of
choice.

It is, though, because of its high risks, the treatment

of last resort.

One recent concern expressed has been that
i

general surgeons will take this procedure lightly and perform
too many (239)*

This would be tragic.

However, a good number

of medical centers have the facilities, manpower, and profes¬
sional expertise to successfully integrate surgery, medicine
and psychiatry into a team to work with bypass patients.

To

not ansv/er this therapeutic need would be a grave omission for
a qualified medical center.

Another surgical approach to obesity is that of gastric
surgery.

Either by gastroplasty or a gastric bypass that ex¬

cludes the distal 90% of the stomach, the small stomach reser¬
voir insures limited food intake through the deterrent of the
dumping syndrome.

Mason, who has had the greatest reported exper¬

ience with the gastric bypass, found weight losses for his pa¬
tients comparable to those found in the intestinal bypass
literature, and with less mortality and morbidity (240, 241).
The 4.6% overall mortality for the gastric bypass, however, is
reduced to 2% for the gastroplasty, although the weight losses
seem less reliable after the latter procedure.

Fundamentally,

the gastric procedure patients are less disabled than those with
the intestinal bypass because the former only limits intake.

\
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while the latter limits absorption (202).
proven procedure,

Although a less

the gastric bypass or gastroplasty ought to

be considered as an alternative to the intestinal bypass,

and

may be particularly useful for those massively obese patients
for whom the malabsorptive side effects of the intestinal by¬
pass would be prohibitive.

Numerous other treatment methods have been used for obesity.
Those reviewed here,

it was

judged,

represent the mainstream

of the medical art of obesity therapy.

Undoubtedly,

other

methods have often been used successfully if only infrequently.
A new and novel method often has an appeal advantage over a
more traditional one.

Methods such as hypnosis and fad diets

can be successful in the short-term but there is little evidence
supporting their effectiveness for long-term weight control.

(3)

In addition to novel approaches that actually have some patho¬
physiologic basis,

there are others that do not.

duction is a big business,

Weight re¬

and profit-seeking in this field is

a strong incentive to push a reduction method or adjunct re¬
gardless of its proven effectiveness.

Furthermore,

obese pa¬

tients are often prime candidates for quackery when a personal
history of failure exists and the physician-patient rapport
has been tarnished.

A physician can best protect his patients

from quackery by maintaining an educating, sympathetic, and
supportive role.

Summary and Conclusions

The definition,
gorization,

measurement,

prevalence,

hazards,

cate¬

and etiology of obesity were reviewed in the

previous section.

It was concluded that obesity is a patholo¬

gical entity which is clinically measurable and carries with it
distinct risks and consequences to one's physical,
and social well-being.
ous and varied,
state,

emotional,

The risks and consequences are numer¬

are often of unclear connection to the obese

and vary in reversibility resulting from weight reduction.

Evidence favors the conclusion that weight reduction is desir¬
able for many and probably most obese

individuals.

The risks

of obesity generally are proportional to the degree of adiposity,
and weight loss can be urgently needed especially in massively
obese patients and those with medical complications.
As the etiology thus far determined is multiple and complex,
it is not surprising that multiple therapeutic approaches would
be available.

The principles, methods,

effectiveness,

hazards,

indications and contraindication for the treatments for obesity
have been discussed in this section.

Numerous approaches exist,

reflecting the various etiologic influences,
some extent,
and hazards.

and differ,

to

in terms of short- and long- term effectiveness
All methods carry some risks and costs, varying

in a spectrum from the most benign and conservative to the most
radical.

It has been stressed that because different treat¬

ment schemes are best applied to different patients,

the physi-
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cian should take a dynamic and flexible approach in which risks
and consequences of nontreatment are comparatively considered
against the risks, costs, and long- and short- term benefits
of various treatment modalities.

The following table may serve

as a guide to quickly generalize the hazards and benefits of
different treatments.
TABLE 6
TREATMENT

ADVERSE RISKS AND
CONSEQUENCES
V

COSTS AND
INCONVENIENCE
0-5

SHORT TERM
SUCCESS

LONG TERN
SUCCESS
. ..... . _.. _ ^
)\

Low calorie
diet

1

1

1

1

Free diet

1

1

2

1

Self-help groups

1

1-2

3

?2

Behavior modifi¬
cation

1

1-2

3

?3

Psychot herapy

1

3

l

?2

Amphetamines/diet

2

2

2

1

rhyroid/diet

3

2

3

1

Fast

4

4

5

2

Bypass

5

5

4

5

The above chart is limited in usefulness in that it cannot
take into account the specific case of the patient for whom
treatment is being considered.
further consideration.

Several points are worthy of
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AD VERSE RISKS AND CONSEQUENCES.

Every treatment carries

with it at least some risk, as the change in eating behavior
required for even the most benign treatments can be a psycho¬
logical stress for some obese patients.

If the patient for

whom conservative treatment might precipitate a "dieting de¬
pression" can be identified during pre- or early treatment,
then a decision not to treat such an obese individual might be
appropriately made.
COSTS AND INCONVENIENCE.

A low calorie or free diet re¬

quires ongoing support and follow-up by a physician, nutritionist
or other health care provider.

If drugs are added to the program,

both patient responsibility and physician/provider time may be
increased.

Self-help groups are generally less expensive on

even a weekly basis than less frequent physician visits, and
members often view the meetings as socially pleasurable rather
than inconvenient.

However, for some, an added dimension of

compliance beyond just diet makes the self-help groups some¬
what more inconvenient.

This is especially true for men, who

rarely find these groups satisfying and effective.

Behavior

modification generally requires a leader's time - not necessarily
a physician - with some understanding of the treatment method.
However, bibliotherapy may prove to be an efficient alternative
requiring a minimum of professional services.

For the patient,

it v/ould seem that compliance with behavior modification methods
would be of moderate inconvenience.

Psychotherapy is an ongoing

procedure which is quite costly, in most cases.

Fasting is
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highly inconvenient and costly on an inpatient basis, but
much less so if feasible as an outpatient.

Surgical bypass

is far greater in terms of cost and inconvenience than any
other method.
SHORT TERM SUCCESS.

Individual successes vary, and the

chart does not take into account, for example, the patient who
will do better with the rigid guidelines of a strict low calorie
diet as opposed to the more liberal approach of the self-help
groups.

The hysterical personality style may respond quite

differently to a treatment approach than an obsessive-compulsive
It is a challenge for the physician to provide a regimen for
his patient that is sufficiently individually syntonic with
his character, needs, and motivation to maximize chances for
success.

Furthermore, chances of success can be increased con¬

siderably by factors intrinsic to the physician-patient relation
ship.

These variable constant, evidence suggests that the short

term success of the traditional conservative treatment methods
(diets, amphetamines, psychotherapy) are generally poor to fair.
The newer and less researched conservative mthods (self-help
groups and behavior modification) are generally more promising.
Only the fast and bypass have proven to be reliable methods for
weight loss.
LONG TERM SUCCESS.

Of greatest importance in the treat¬

ment of obesity is the long-term success.

Unfortunately, much

less is known about the long-term effectiveness of different
methods than the short-term success.

While the latter is often
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moderately good v/ith conservative methods, the former has
traditionally been poor.

Conservative methods that help

change eating habits and behavior would seem to offer some
advantages towards long-term weight control, but few studies
have been conducted to verify this.

There is little to lead

one to suspect that fasting is especially effective in the
long run.

The only treatment for obesity known to be on long¬

term effectiveness is surgery.

SUMMARY OF SUGGESTED TREATMENTS FOR PATIENTS OF VARYING DEGREES
OF OBESITY
Mild-moderate obesity
(0-20^ overweight)
1- Self-help grouos.

If a quality organization exists in the

community, this may be considered a first-line approach for
women with mild to moderate obesity.

Patient interest as a

prerequisite, the physician ought to take the responsibility
of patient follow-up and continued support so that another
method can be used if this approach fails.

Occasionally, men

interested in these groups (such as Weight Watchers or TOPS)
may be good candidates.
2- Behavior modification.

This newly utilized approach appears

to be the treatment of choice for mild to moderate obesity.
Unfortunately, the availability of this method for obese pa¬
tients remains very limited at this time.

It is hoped that the

resources will be rapidly developed so that patients can benefit
from this promising approach to obesity.
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3-Low calorie diet,

A safe and simple approach, it may be

effective with some patients, particularly those most motiv¬
ated, but usually is ineffective.

Physician support is

important.
A—Free diets.

Also safe and simple, some patients will do well,

particularly those well-motivated and within the context of
strong physician-patient rapport.

Long-term management is

generally poor.
5- Amphetamines/diet.

Anorexiants may be used as adjuncts for

these patients, particularly to help a patient start a "dif¬
ficult" diet.

Generally, these agents offer little above diet

alone for long-term weight control.
6- Psychotherapy, thyroid, fasting, surgery.

These more hazard¬

ous and/or costly methods can rarely be justified to treat this
group of obese patients.

Moderate-severe obesity
(20/-40/ overweight)
1- Self-help groups.

These groups may be effective for these

patients, particularly women who have had previous success
with them.
2- Behavior modification.

Although only several studies exist,

behavior modification is probably the best first line treat¬
ment when available for this group of patients.
3- Low calorie, or free diet.
succeed on these regimens.

Few patients in this group will
Hov/ever, some highly motivated

-87patients may, and more hazardous treatments may prove unneces¬
sary.

Recurrence is very high.

4- Amphetamines/diet.

Some patients may benefit from the grati¬

fication of more rapid weight loss that these drugs may con¬
tribute to, but for most patients, the benefit of adding
amphetamines to a good diet regimen is marginal.
5- Thyroid/diet.

For carefully selected patients with close

supervision, thyroid hormone may be used to contribute a
successful weight loss.

However, cessation of hormone treat¬

ment may lead to greater difficulty in maintaining the loss.
o-Fasting.

Inpatient starvation is severe treatment for these

patients, but where rapid weight loss is strongly indicated, it
may be necessary.

Outpatient fasting or semistarvation is also

rather severe, but could be well worthwhile for those patients
for whom the above methods have failed, are contraindicated, or
unavailable.
7- Psychotherapy.

This may be of great importance for certain

patients for whom conservative treatment failure is evident
and psychologic factors appear to be dominant.

Unfortunately,

both patient refusal and high cost of treatment often neces¬
sitate that this modality be underutilized.

Of course, psycho¬

therapy is only an adjunct to a weight reduction method.
8- Surgical bypass.

This hazardous approach would rarely, if

ever, be indicated for this population.
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Severe obesity
00/o-~60fo overweight)

(k

1- Solf-help groups, diets, amphetamines.

Only occasionally will

patients of this degree of obesity do well with these regimens.
They require large weight losses for adequate treatment, and
recurrence is likely.

If treatment failure has not occurred

in the past with these conservative methods, a treatment trial
may be worthwhile with the hope that more radical methods may
be avoided.

However, most of these patients have a history of

failure v/ith these methods.
2- Behavior modification.

There is some evidence that this

approach may be effective for this group.

Further experience

will better resolve this issue, but at this point in time a
trial of behavior modification could be worthwhile.
3- Thyroid/diet.

Although more hazardous than conservative

measures, thyroid can be an effective adjunct to diet contri¬
buting

to a successful weight loss.

However, it has little or

nothing to offer above more conservative methods for long-term
weight control.
4- Fasting.

If conservative treatment methods fail, these patients

ought to be considered for a period of supervised starvation
or semistarvation.

For most, a semistarvation trial (a pro¬

mising method by recent reports) would not be unreasonable.
For many, including those for whom outpatient semistarvation
is not successful, a supervised hospitalised fast should be
tried with the hope that this successful weight loss will be
maintained.
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5- Psychotherapy.

Counseling is probably indicated for most

patients in this group with a history of treatment failure.
Unfortunately, this is often not practical or possible.
6- Surgical bypass.
in this group.

Surgery may be indicated for some patients

Not only must their obesity be of sufficient

severity and consequence to their well-being, but also a
documented history over a period of years of treatment failure
with conservative methods, fasting, and preferably, psycho¬
therapy.

Of course, motivation and full informed consent are

also prerequisites.

Massive obesity
(-> 60% overweight)
1- Self-help groups, diets, amphetamines, thyroid.

These treat¬

ments will only rarely be of significant benefit for the mas¬
sively obese.

However, if conservative methods have not been

tried, there is little to lose by initiating a trial for a
limited period of time.

Strong physician support is needed if

a conservative method is to have any chance of success.

Even

if weight loss is achieved, recurrence is likely.
2- Behavior modification.

Evidence is lacking as to whether this

method is of use for this group.

However, since it is benign

and early reports have been promising for its usefulness in the
moderately obese, a trial may be worthwhile.
3- Fasting.

Fasting should be considered an indicated treatment

for these patients after a history of treatment failure with
more conservative measures.

With the help of counseling and
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support, and other learned means of weight control, it is hoped
that surgery will not be necessary.
4- Psychotherapy.

Most of these patients could potentially

benefit from the insight gained through this therapy.

Psycho¬

therapy should be considered an important, if not necessary,
adjunct to weight reduction therapy for the massively obese.
Of course, some patients may refuse this therapy.
5- Surgical bypass.

This "last resort" treatment may be indicated

in a fair proportion of the massively obese group.

A history

of treatment failure including conservative approaches, fasting,
and psychotherapy should be documented, as well as a clear and
serious health threat as a result of intractable massive obesity.

Obesity, is a potentially treatable disorder that produces
a variable but definite hazard to the health and well-being of
an

individual.

The physician has the responsibility to devise

a treatment program in conjunction with his obese patient that
is in the best interest of the patient.

Although successful

treatment is difficult to achieve, particularly in the long
run, a number of different treatment approaches can be used.
Used appropriately in a conscientious program of ongoing com¬
mitment, the chances for successful treatment are maximized and,
it is proposed, greater than that that has traditionally been
achieved.
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A FOLLOW-UP STUDY OF FASTED PATIENTS

INTRODUCTION

The treatment of obesity has been reviewed in the previous
sections.

It was concluded that simple obesity is a complex

state resulting from a positive caloric balance but contributed
to by multiple inputs.

Likewise, a variety of treatment op-

proaches are available that can be used to maximum effectiveness
when a thorough knowledge of both patient and treatment method
exist.

Massive obesity, previously defined, poses a great chal¬

lenge to the physician as these unfortunate patients carry the
greatest risks and consequences from their obese state and are
usually refractory to conservative weight reduction methods.
Fasting has developed as a major means of medical management
for the intractable massively obese.

As previously discussed,

fasting has been in reported use for over fifteen years, during

which time its effectiveness for rapid weight loss has been
well documented.

(203, 205-207).

Used in a hospital setting

with careful supervision, the fast is generally well-tolerated,
although minor side effects are common, the nutritional state
is drastic, and, rarely, life-threatening complications will
occur (21, 212, 213, 215, 216).

In a program in which patients

are well-screened, inpatient monitoring appropriately executed,
and preventive measures taken, most complications can be pre¬
vented or well-controlled.

Although most fasts are terminated

within two months, longer fasts have been reported and welltolerated (21, 206),
While the reliability of acute weight loss for hospitalized
fasters is good, the benefit of fasting for long-term weight
control is far less clear.

Some authors have claimed that

their fasted patients received benefit beyond

the fasting weight

loss in that positive feedback from a successful loss, changed
eating habits, and the ease of not eating were important learned
experiences contributing to long-term weight control (203, 205,
207, 208).

However, the few follow-up studies found in the

literature show modes and inconsistent long-term weight control
for those fasted (208-210).

While the inpatient phase of weight

loss is rather easily executed with consistent success, the out¬
patient post-fast period is far more variable in terms of pa¬
tient reponsiveness, appropriate treatment and the multitude of
factors that can influence success.
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This study follows up a group of thirteen patients who had
been fasted for varying periods of time as inpatients on a meta¬
bolic research ward.

In addition to information directly related

to post-fast weight control,
etiology,

other issues related to the history,

consequences, habits,

hopes,

expectations, knowledge

and insight pertinent to obesity in these patients was explored.
These results will be contrasted to our present understanding of
the obese patient and his management.

It is hoped that such in¬

formation can contribute to the successful management of obese
patients

on an individualized basis and also help illuminate

important common characteristics

of the severely obese.

PATIENTS AND METHODS

Thirteen patients had been fasted on a metabolic research
ward at Yale-New Haven Hospital for varying lengths of time
within the period from November 1973 to November 197^»
were under the care of Dr.

Robert Sherwin, a metabolic fellow

(under the supervision of Dr.

Philip Felig) and later an assis¬

tant professor of medicine at the Yale Medical School.
were referred to Dr.

Sherwin via several routes,

screened by the following criteria:
(flexible),
disease,

Patients

and were

1-rule out unhealthy

especially those with severe hypertension, heart

diabetes mellitus,

or gout;

3-preferable at least 50%> overweight;
by fasting.

All

2-preferably young;
4-motivated to lose v/eight

Prospective patients were to understand and consent
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to an inpatient stay which included within it a fast and also
metabolic studies requiring either ketone infusions that were
to test the effects

of ketone acids on urea nitrogen excretion

and circulating amino acids or glucagon infusions that were to
test the effects of fasting on glucagon kinetics.
costs were covered through research funds.
consent,

All patient

After full informed

patients were admitted to a research ward which was

predominantly filled with non-obese patients suffering from
other ailments.

Patients were first placed on a calorically

controlled maintenance diet
various lengths of time,

(generally 3000 calories)

for

and then fasted with 0 calories for

duration varying betv/een 17 and 70 days.

One patient was calor¬

ically restricted for an extended period before fasting was
begun.

All admitted patients received complete histories and

physical examinations.
magnesium,

Electrolytes,

liver and renal function,

calcium,

protein,

blood count were measured periodically.
daily.

While fasting,

and

Patients were weighed

1 mg of folic acid,

625 mg

intermittent potassium supplements as needed,

allopurinal if hyperuricemic,
static hypertension occurred.
Dr.

thyroid,

patients were given daily 2 liters of

water (minimum), multivitamins,
sodium bicarbonate,

phosphorous,

and supplemental salt if ortho¬
Patients were seen daily by

Sherwin, who would spend on average about twenty minutes

with each patient.
used,

Psychiatric consultation was sometimes

and counseling (in addition to Dr.

often recommended.

Shwerwin's role) was

Fasting was generally terminated when metabolic
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studies were complete.

Patients were then placed on a 150 to

200 calorie diet and were gradually increased to a regimen of
600 calories over a period varying from one to three weeks and
then discharged.

As outpatients,, patients were instructed to

use diets generally between 600 and 1000 calories.

Dr. Sherwin

followed all these patients, seeing them on a flexible schedule
of once per week or less frequently.
All thirteen medical records were reviewed for data re¬
lated to the fasting hospitalization.

Follow-up data was not

consistently available in the medical record.

With Dr. Sherwin’s

cooperation, an attempt was made to plan an interview between
each patient and the author at the Yale-New Haven Medical Center.
Through a planned but flexible format of questions, the inter¬
view would explore relevant areas of weight and treatment history,
the personal consequences of obesity, eating and exercise habits,
the fasting experience, the follow-up period, and personal opin¬
ions and insights about the treatment of obesity and their weight
problem.

The length of the interview would vary between 45 and

90 minutes.

The research protocol was reviewed and accepted by

the Yale Human Investigation Committee.

An outline of questions

covered in the interview appears in the appendix.

RESULTS

THE FAST AND FOLLOW-UP
Medical records were reviewed for all thirteen patients
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and data was collected for age, fasting dates, admission
weight, pre- and post-fast weight, and hospital course.

Follow¬

up data was available only through patients interviews of
Dr. Sherwin's private records.

Patients ranged between 19 and

51 years of age, with a mean age of 31.6 .

Eight were v/omen,

v/ith an average weight of 251 pounds, and a range of 182 to
350 pounds.

Five men were fasted, averaging

range of 310 to 655 pounds.

463 pounds with a

The average weight for all 13 pa¬

tients was 308 pounds while the median was 264.

The degree of

obesity expressed as a percentage above maximum ideal weight v/as
calculated.

Using height and weight tables and assuming large

frame body type the % overweight ranged from 20% to 206% with
an average value of 88% and a median of 86%.

Fasts ranged from

17 to 70 days, v/ith a mean and median of 34.6 and 31.5 days
respectively.

The patient v/ho fasted 17 days terminated his

fast by eating for several days while out of the hospital on
pass.

He returned to the hospital 20 pounds heavier and re¬

newed his fast for another 23 days.

All other patients completed

their fasts successfully, terminating according to physicain
orders.

Minor cheating episodes were occasionally reported,

but did not seem to significantly affect weight loss rates.
Patients v/ere frequently granted passes to leave the hospital
when it v/as important for them to do so.

Weight loss by fasting

averaged 43.4, with a median of 40 and range of 20 to 71 pounds.
The average loss per day v/as 1.27.

Loss per day was calcu¬

lated to correlate with initial weight with an r value of
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+ 0.64 (p< 0.05).

(All computation schemes in appendix).

The correlation between loss
to r= -0.62 (p<0.02).
20 pounds,

per day and days fasted calculated

All thirteen patients lost more than

and 8/13 lost 40 or more pounds.

Reduction indices

ranged between 36 and 94, with a mean of 63 and a median of 66.
Up to date follow-up data was available for 8 patients.
For the five patients for whom current weights were not avail¬
able,

a follow-up weight for their last physician visit was

available for all but one.
0.and

Follow-up duration ranged between

15 months, with a mean of 7.1 and median of 8 months.

Follow-up weight change ranged between 43 pounds lost to 255
pounds gained, with a mean of
of 0

(no weight change).

29.8 pounds gained and a median

Expressed as a function of time,

the

monthly weight change ranged from 4.4 pounds lost to 23.2
pounds gained, with a mean value of 4.2 pounds gained and a
median of 0.3 pounds gained.

Testing correlation between

duration of follow-up and weight change
patients,

(gain)

an r value of +0.47 was calculated

for these

(p<0.10).

For the 8 patients with up-to-date follow-up data the mean
follow-up interval is 8.3 months,

the mean weight change is

17*1 pounds gained and the mean monthly change is 2.1 pounds
gained.
Interviews were held with 8 of the 13 patients.

All five

of the non-interviewed patients are currently lost to Dr.Sherwin’s
follow-up.
him.

Only one of the eight interviewed had stopped seeing

No patients refused to be interviewed,

but 5 were unable

-
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to be located or reached.
pital discharge to the date

The mean duration of time from hos¬
of this study (interviews)

is

12 months for those not interviewed and 8 months for those
interviewed.

All of the following data was collected only

from the 8 interviewed patients.
Major reason for seeking treatment by fasting:
physical problems -4,

desperation -2,

health or

job requirement -1,

self-satisfaction -1.
Hopes and expectations for fast:
loss -6,

30 to 70 pound weight-

to successfully eat nothing -1,

no expectations -1.

3/8 of the patients mentioned continued weight loss after
fasting as a major expectation.
Fears

of fasting: none-4,

failure -1,

intravenous infusions -2,

regain of weight -1.

General quality of fasting experience:
accepted -7, bad experience -1,

easy or well-

The latter patient described

the fast period as "one of the most difficult experiences
in my life."
Best aspect of fasting experience:
ability to lose weight -4,
patients -2,

weight loss and/or

interactions with fellow obese

nothing -2.

Worst aspects of fasting experience:
culties -4,

boredom or confinement -5»

Of these latter 4 patients,

emotional diffi¬

physical difficulties -4.

3 had some problem with orthostatic

hypotension and 2 had muscle spasms after receiving a ketone
infusion (1 of these patients had hyperventilated).

Difficulty

100.
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coping with very ill or non-fasting patients on ward -3,,
coping with forced regimen -1.
Hunger:

none -3»

several days -3»

one week -1,

entire

fast -1.
Post-fast change in eating habits:
follows diet -1,
Use of diet:

none -3»

slight -2,

can eat considerably less -2.
poor or no adherence -3» moderate adherence

(500 calorie) -1, generally good adherence (600-800 calories
or free diet)

-4,

Frequency of medical follow-up:
6weeks -4,

irregular and rare -3,

regular and at least once/

presently lost to follow-up -1.

The average post-fast weight change for the four patients who
regularly see their physician is -18.50 pounds.

For the other

four patients the average is +52.75 pounds.
Purpose of follow-up visits:
control -5,

general support for weight

check weight and diet -2, not sure -1.

General satisfaction with fasting as treatment for obesity:
yes - 6, no - 2.

The most successful post-fast weight loser felt

that the- fast was a good way to start a big weight reduction,
proving to herself that she could lose weight and feel better.
Two-patients felt that fasting was emotionally difficult.
One faster criticized the method because it doesn't get to
the root of the problem.

"I can't fast my entire life,"

he said.

WEIGHT HISTORY.

Family:

4.

-

both parents obese -4,

only one parent obese

(mother)
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Obesity onset:

infancy and early childhood -3»

childhood and early adolescence -2,

late

late adolescence and

early adulthood -3.
Precipitating events for weight gain:

emotional stress-7»

Of these 7 patients 4 were able to specify important life
events that preceded significant weight gain.

Pregnancy -1,

none -1.
Pattern of weight change since onset:
gain -1,

gradual gain with plateaus -2,

spurts -2f

gradual gain with marked

gradual gain with intermittent losses -3.

Previous treatments for obesity:
diet -8,

constant gradual

fad diets -3»

psychiatric counseling -4,

thyroid -1, Weight Watchers -4„
-1, heat therapy -1,

low calorie or free
amphetamines-7,

? injection therapy -1, hypnosis

previous fast -2.

Best treatment method experienced to date*,

fast -6,

free

diet -1, Weight Watchers -1.
Worst treatment method experienced:
-2,

low calorie diet -1,

don't know -3»

amphetamines

not sure -1.

The ideal way to lose weight:
-3t

fast -4,

stop eating -1,

a pill that burns up calories
good habits/prevention -1.

EATING AND EXERCISE HABITS.

Number of regular meals per day:

none-2,

one -1,

two -2,

three -3.
Quantity of intake:

very large -4, moderately large -4.
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Snacking habits;

considerable snacking -8.

patients indentified the evening,

5 of these

one named the mid-afternoon,

and two anytime as the periods during which they snacked the
most.
Food preference;
foods,

none particularly -3*

not sweet or heavily spiced -4,

tasty and savory

sweets -1.

Importance of eating habits for weight control;

very

important -6, moderately important -2.
Are your habits conducive to weight gain?;
Exercise amount;

yes - 8.

none-2, very little -5s moderate -1.

Exercise enjoyment;

dislikes -2, mixed feelings -4,

likes -2.

CONSEQUENCES

OF OBESITY.

Effects on social life and emotional well-being;
ostracism -4,

self-image -2,

job pressure -2,

compensatory personality development -2,

public

romantic life -2,

affects entire life -1,

no effects -1.
Improvement of above effects after successful weight loss;
yes -4,

partial -3» no -1.

Medical history relevant to obesity;
hypertension -4,
problems -3,

mild or borderline

gall bladder disease -3» musculo-skeletal

respiratory difficulties -2,

abnormal glucose tolerance -2,

hyperuricemia -4,

skin abcesses -2,

menstrual irregularity -1, Cushing’s syndrome -1.

phlebitis -1,

-ic-3-

Improvement of health problems after successful weight
loss:

great improvement -1,

some improvement -5»

no change-2.

Specific improvements appreciated by patients included respira¬
tory status,

agility and mobility,

and back pain.

HOPES AND OPINIONS.

Future treatment plans or expectations:
iatric counseling -3f

diet -4,

As one patient put it:

fast -4,

psych¬

exercise -1, s-urgical bypass

-1.

"There is always the fear of putting

it back on."
Hopes for future:
140 pounds,

or 85»

reduce to specific weight

35s 35»

(235»210,235»)

and 0 pounds overweight respectively)

-4? successfully reduce without specific goal -4.
responded:

One patient

"when people will say ’You look good.’"

Best possible treatment for obesity:
and diet -2,

fasting -2,

fasting plus psychiatric counseling and diet -2,

individualized diet -2,

? surgical bypass -1.

Understanding of surgical bypass for obesity:
but risky -2,

fasting

effective

too drastic to be used -4, questionable effective¬

ness but risky -2.
Source of knowledge about surgical bypass:
4,

literature and friends -4.

physician(s)-

DISCUSSION
As has been decumented before, fasting is a highly effec¬
tive method for rapid weight reduction (203, 205, 206, 207s13)«
The average weight loss of 43.4 pounds for these thirteen
patients is considered successful by the criteria of 20
or 40 pound loss or Feinstein's reduction index, for which
he defined as successful a value of 60 or above (102),

However,

these criteria of success were developed before fasting emerged
as an acceptable method for weight reduction in the severely
obese and probably tend to overestimate the success of a fast.
Fasts were generally terminated for these patients when the
incidental metabolic studies were complete and, although an
average reduction index of 63 was achieved, most patients were
still considerably overweight and in serious need of further
large weight loss.
here.

The goal of fasting is called into question

The initial reported series of fasts were of short dura¬

tion, generally 2 weeks or less.

Well tolerated, these fasts

were viewed as beneficial not because of the magnitude of weight
lost, but because they represented to patients a gratifying and
successful running start on weight reduction and control (203,
207).

Later reports indicated that longer fasts could be well-

tolerated with losses greater than 100 pounds (206, 207).
Admittedly, the risks of malnutrition and metabolic derangements
are increased by longer fasts, and Bray had advised that fasts
longer than two months are usually unwise (13).
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Daily fasting weight loss was proportional to initial
weight ( r=+0.64, P<0.05)j as has been reported elsewhere (207).
An inverse correlation existed between average daily loss and
length of fast (r=-0.62, p<0.02)<i

Fluid losses early in the

fast contribute to the greater weight loss seen earlier in the
fast (205).

Reports from the literature average about 2.5

pounds per day lost for short fasts (1 to 2 weeks), and closer
to 1 pound per day for longer fasts (203? 205-207? 209, 210).
The average loss per day for this series of 1.27 pounds over an
average 34.6 days ( 5 weeks ) compares well with that reported
in other series.

That the fast was well tolerated and compliance

generally good for these patients also is in agreement with pre¬
vious reports.

4 of 8 patients did describe the fast as emo¬

tionally difficult, and for one of these the fasting period was
"one of the most difficult experiences of my life.".

The need

for screening out certain patients and/or strong psychiatric
support during the fast is evident.

Another patient commented

that "psychiatry should be part of the program.".

Innovation

and change in the treatment setting and program could improve
the quality of the fasting experience by specifically alleviating
the stresses caused by boredom and confinement, and coping with
very ill or non-fasting patients on the ward.

Physical com¬

plaints were remarkably few, as the common side effects of
orthostatic hypotension and electrolyte imbalances were well
controlled medically* Hunger was a continued problem for only 1
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of 8 patients,

-

consistent with other reports.

theory during fasting has been challenged,

The hunger lack

though (211).

The uncertainty of the issue may be the result of the obese
patient's difficulty in discerning physiologic cues relevant
to his hunger and appetite control (88,

90).

Indeed,

it has

been suggested that the obese are physiologically always hungry

0-2).
The duration of follow-up for these patients

(mean =7.1

months)

is probably too short to consider as long-term.

Bloom's

original report followed-up his

patients 2 to 9 months,

finding that all maintained some of the fasted loss,
maintained most of it

(203).

and most

Hunscher's large follow-up study

which included only 50% of the original patients

- the others

being lost to follow-up - found only one-third of the responders
gained weight since hospitalisation (208).
two-thirds

However,

a total of

of the entire group may have gained if one considers

those lost to follow-up as failures.

Harrison's follow-up report

found 40% of his 62 patients had lost weight 1 year post-fast,
and 24/ showed loss after 2 years
most discouraging,

(209).

McCuish's study was

finding all his patients had gained weight

after an average of 14 months of follow-up (210).
study,

In the present

follow-up data was current for 7 of 13 patients,

age quite consistent with Hunscher's experience.

percent¬

However,

retrospective follow-up data was available for 12 patients.
4/12 regained all their lost weight,

2/12 regained some,

and

-ic 7-

6/12 lost weight since hospitalization.

Again,

remarkably similar to Hunscher's results.
the patients in this present study,

this is

It was noted that

like Harrison's and

Hunscher's patients,

tended to fare poorer as follow-up

duration increased.

Weight change correlated with follow-up

results to appear less successful as the duration of follow-up
increases.

While

only 2 of 8 patients felt their eating habits

had been significantly changed since fasting,

only 3 out of 8

felt that the fast had no effect at all on their eating habits.
Bloom and Drenick reported that their patients felt that they
had benefitted in terms of improved eating habits

(203).

Only

4/8 of the present group of patients have been able to success¬
fully use a diet after their fast.

6/8,

though, were generally

satisfied with fasting as a treatment method.

Although most

realized that fasting did not get to the root of their problem,
they were still gratified by their experience with a method
with which they were able to lose a considerable amount of weight.
The usefulness of fasting in a long term weight reduction and
control program for severely obese patients as evidenced by this
study’s

population remains limited.

A few patients seem to have

benefitted significantly, whereas they had not been successful
with more conservative methods previously.
it would seem,

Several patients,

did not benefit at all from the fast.

Factors

which influence success may be hypothesized based upon inter¬
view data, but the population studied is far too small from
which to draw any conclusions.
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A number of interesting patterns emerged from the inter¬
view data.

These patients, with long and often life-time

histories of obesity, coming from homes with obese parents,
showed considerable insight into their condition.

7/8 could

identify emotional stress as a major precipitant for weight
gain.

A/8 have had experience with psychiatric counseling.

Patients v/ere also v/ell aware of the role that eating habits
play in their obesity.

All 8 could admit that their food in¬

take was large and snacking excessive.
frustration was evident.

Nevertheless, their

One patient, who states that

"insight helps," sadly admitted:

"I’m addicted to food," and

"I love food more than I love myself."
"I hate myself when I'm eating."

Another disclosed,

What becomes clear is that

what most of these very obese patients require is not so much
advice, moralizing, or education about the basics of diet,
but rather, support, understanding, and professional counseling.
The patients were also aware of many of the consequences
of their obesity.
cism.

Most striking to them was the public ostra¬

"People don't understand obesity," one patient stated.

Another admitted that he felt a closeness to fat people, and
that they were all going through the same thing.
that there is little variation in obese people.

Another felt
The potential

value of group discussion for these patients is evident.

Most

patients were also aware that their obesity had affected their
character and emotions.

Only one patient denied any effects
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of obesity to his psychosocial well-being.
were also noted.

Health effects

Half of these patients sought fasting be¬

cause of physical problems or fears.

However, many of the

effects were of the nature of chronic disease risk factors as
opposed to present symptomatic difficulties.
Unfortunately, only one patient felt great improvement of
his problems as a result of experiencing weight reduction.
However, most felt some improvement and would probably benefit
more if more excess weight were lost.

Most patients found

the weight loss achieved through fasting as gratifying in a
variety of ways.
All these patients had a history of failure with other
weight reduction methods.

Diet and amphetamines stand out as

the most frequently used unsuccessful methods.

Two patients

had had previous fasts and then regained the weight.

Several

patients had tried methods that have no sound basis for the
treatment of obesity.

It is noteworthy that 6 out of 8 pa¬

tients felt the fast was the best treatment they had exper¬
ienced, but that 4 of 8 patients also mentioned the fast as the
worst treatment experienced.

The success of the weight loss

was undoubtedly gratifying for these patients, while the
awareness that fasting may not be worthwhile in the long run
also is present.

Frustration is reflected in the responses to

the fantasy question:

"What would be the ideal way to lose

weight, if it were possible?".

Three patients were able to

fantasize an energy burning pill, not too unlike the now
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prohibited agent dinitrophenol (143).
unable to imagine any ideal treatment.

Three others were
Concerning the

surgical bypass, 6/8 had negative attitudes.

Physicians,

particularly non-surgeons, often have strong prejudices
against risky surgical procedures.

Evidence strongly favors

that surgical, bypass can be used effectively in properly
selected massively obese patients

(13, 22?~232, 239).

To

pass on a contrary opinion to patients is not fair, as it would
be equally inappropriate to lead a patient to believe that such
surgery is v/ithout considerable risks and side effects.
All patients expressed hope to be able to reduce.

Some

set specific goals which were to a variable degree above their
maximum ideal weight.

4/8 expected to fast again if need be

in the future, 4/8 expected to rely on diet, and 3/8 mentioned
the use of psychiatric counseling.

The information gathered through the interviews, while
not sufficient in this small group to draw significant specific
conclusions, does tell us a great deal about the very obese
patient.

He is generally an individual who has lived with

obesity, treatments, and consequences for a long time, and has
some insight into and considerable awareness of the behavioral
aspects and consequences of his obese state.

Despite all his

experience, he is frustrated by the elusiveness of success.
Several themes emerged that are relevant to specific treatment
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methods:
1 - Many of these patients are excellent candidates for psy¬
chiatric counseling.

They come motivated and with a modicum

of insight into their problem.
2 - Many of these patients are reasonable candidates for
behavior modification.

They are motivated and aware of their

bad eating habits and its importance in obesity.

Although

the efficacy of behavior modification for patients this obese
is still not sufficiently proven, Stunkard's study is promising
(191), and a trial for these patients would seem worthwhile.
3 - Many of these patients could benefit from group therapy.
The burdens of obesity are considerable, and the group process
offers patients a unique support system that often cannot be
reproduced by an individual therapist.
4 - For most of these patients fasting was generally a gra¬
tifying experience.

While they tend to desire refasting to

achieve a rapid weight loss, they also realize that the fast
alone often does little to insure long-term successful weight
control.

If recurrence occurs, or another major weight loss

is needed, outpatient semistarvation as described by Genuth (218)
is a promising and relatively safe method that could be worth¬
while for these patients.

Data about the fast and follow-up tend to support that
which has emerged as a consensus from the medical literature:
Fasting is effective for rapid weight reduction and is well
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tolerated with side effects and metabolic derangements well
controllable.

While most patients will not do well in terms

of long-term weight control, some seem to benefit considerably
whereas previous conservative methods had failed.

Fasting has

an appropriate place in the spectrum of treatment for the
extremely or massively obese patient.

It ordinarily ought to

be utilized after less radical methods have been given a fair
trial and proven ineffective, and usually in conjunction with
professional counseling or supportive therapy to maximize suc¬
cess.

If fasting proves ineffective in controlling massive

obesity, alternative methods need be considered, including
surgical bypass.

A thorough understanding of an obese patient's

weight history and experience, insights, feelings, and opinions
about obesity and treatment can contribute to the planning of
an appropriate and effective weight control program.

APPENDIX

IC OUTLINE OF INTERVIEW
I. Introduction - greeting and explanation of project
II. History
A.
General medical
B.
Obesity
1.
family:
"Have other members of your family been
overweight?"
2.
onset and precipitating factors:
"When do you
first recall becoming overweight? Can you recall
things that happened in your life that preceded
or somehow caused you to eat more or gain weight?"
3.
course - weight chronological history
4.
Treatments - successes, failures, opinions:
"What
method for losing weight has been best for you?...
Why? Which methods didn't work?...Why? What
would be an ideal way to be able to lose weight
if it were possible?"
5.
consequences
a.
social:
"Do you think being heavy has effected
your social life?...How?...Any different after
weight loss?"
b.
psychological: "Has being overweight effected
your personality?... Your feelings?... Your
mood?...Your behavior? Any different after
weight loss?"
c.
medical:
"How has being heavy effected your
health? Any change after weight loss?"
6.
eating habits
a.
Meals - #f quantity, time, dieting, snacks
b.
foods - preferences
c.
insights:
"Do you think eating habits are
important in maintaining or changing weight?
Are your eating habits conducive to main¬
taining or losing weight?...Why (not)?"
7.
excercise - amount, frequency, pleasure derived
III. Fasting experience
A.
Motives and expectations:
"Why did you accept this
treatment? V/hat were your hopes and expectations
of its success?... Any Fears?"
B.
Feelings, opinions about fasting experience:
"How
did you feel about fasting once you had started?
...Like or dislike?... What and why?...Any hunger?"
C.
Results - short and long term
1.
post treatment course --- present:
weight
2.
eating habits, diet adherence:
"Any change in
eating habits? Are you using a diet?...Which?
...Stick to it?"
3.
medical follow-up:
"Have you been seeing a doctor
about your weight or health since you left the
hospital?... How often?... What does he do or tell you?"
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IV.

V.

TT7

"Prognostics"
A.
General satisfaction with fast as treatment; "Are you
satisfied with fasting as a method by which you can
lose or control your weighs?"
B.
Plans for future treatment:"Do you expect to undergo
a weight reducing regimen again? Which Method?... Why?"
C.
Hopes
1.
Weight problem - the future?: "Do you think weight
will be a problem for you in the future? Why?"
2.
Best treatment: "In your opinion, what is the best
treatment for overweighs, including diet, exer¬
cise, medicine (pills), surgery, or any other
method?.,.Why?"
3.
"What do you think or know about surgery for con¬
trolling weight? How did you learn this?"
Closing
A.
Questions?
B.
Thanks and well wishes
Correlation between average daily weight loss and initial weight
Simple linear correlation was sested, using the formula for
the Pearson product-moment, correlation coefficient, r, where-"/
Zxy

(Mlv'
1±
(£x)a'
n

(yv z _ (£y)aN
n

‘

where:

x = average daily v/eight loss
y = initial weight
n = fasted patients
Probability was tested for a s value, where:
t = r
1.1 J ,

Correlation between average daily weight loss and number
of days fasted.
r coefficient calculated as above, where:
x = average daily weight loss
y = number of days fascsd
n = fasted patients
t and probability calculated as above.

IT.

Correlation between duration of follow-up and weight change
since hospitalization.
r coefficient calculated as above, where:
x = duration of follow-up in months
y = change of weight ir. pounds since hospitalization
n = fasted patients wish follow-up history

^Formula from J.

Ipsen, P. Feigl:

Bancrofts Introduction to
Biostatistics, New York, Harper,
— —
1970.
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